ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001045.1|Spiruchostatin_1 # 2 # 106 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.562	BGC0001045.1|Spiruchostatin_1 	2	106	+	Loose	2030	20.0162	ceoB	46.67	3003010	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GATCGTTCGAGAGAGGACTTAAGCGGGAAAGTACTTTCGCGCCTCCTCGGTGGTATAGCGCAGGAAGATCTGCACAGCCTGCGGAATCAGGCGTCGTGTGAGTAG	DRSREDLSGKVLSRLLGGIAQEDLHSLRNQASCE	MNISKFFIDRPIFAGVLSVIILLGGVIAMFLLPISEYPEVVPPSVIVKAQYPGANPKVIAETVASPLEEQINGVENMLYMQSQANSDGNMTITVTFKLGTDPDKATQLVQNRVNQALPRLPEDVQRLGITTVKSSPTLTMVVHLISPDNRYDMTYLRNYALINVKDRLSRIQGVGQVQLWGSGDYAMRVWLDPQKVAQRGLSAEDVVQAIREQNVQVAAGVIGASPSLPGTPLQLSVNARGRLQTEDEFGDIVVKTTPDGGVTHLRDIARIQLDASEYGLRSLLDNKPAVAMAINQSPGANSLQISDEVRKTMAELKQDMPAGVDYKIVYDPTQFVRSSIKAVVHTLLEAIALVVIVVIVFLQTWRASLIPLIAVPVSIIGTFSLLLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIENGMNARQATYKAMQEVSGPIIAIALTLVAVFVPLAFMSGLTGQFYKQFAMTIAISTVISAFNSLTLSPALSAILLKGHGDKEDWLTRVMNRVLGGFFRGFNKVFHRGAENYGRGVRGVLSRKTLMLGVYLVLVGATVLVSKVVPGGFVPAQDKEYLIAFAQLPNGASLDRTEKVIRDMGSIALKQPGVESAVAFPGLSVNGFTNSSSAGIVFVTLKPFAERHGKALSAGAIAGALNQKYGAMKDSFVAVFPPPPVLGLGTLGGFKMQIEDRGAVGYAKLSDATNDFIKRAQQAPELGPLFTSYQINVPQLNVDLDRVKAKQLGVPVTDVFNTMQVYLGSLYVNDFNRFGRVYQVRVQADAPFRQRADDILQLKTRNDKGEMVPLSSLVTVTPTFGPEMVVRYNGYTAADINGGPAPGFSSGQAQAAVERIADETLPRGVRFEWTDLTYQQILAGDSAMWVFPISVLLVFLVLAALYESLTLPLAVILIVPMSILSALTGVWLTQGDNNIFTQIGLMVLVGLSAKNAILIVEFARELEHDGRTPLEAAIEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMLGVTLFGLI	3.31	gnl|BL_ORD_ID|1148|hsp_num:0	1252			1512	1557	
BGC0001045.1|Spiruchostatin_2 # 470 # 1021 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.620	BGC0001045.1|Spiruchostatin_2 	470	1021	+	Loose	275	28.1054	AAC(6')-Iq	27.34	3002560	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGCAGGCCGGCGCCTTGGGTGATGCCCGTCAGGTCGATCTTGTCGCTGCCACTGGTGAAGTCGAGGATCTGGTCTGCCGCCCCCGGTTTGGAGTCAGAGCTGGCGCCAAACACGAAGGTGTCAGCCCCGGCGCCACCCCACAGTTGATCCGTTCCGCCACCACCGTAGAGCACGTCATTGCCCGCGCCACCCTTGAGTACGTTATCCGCGGTGTTGCCCACCAACAGGTCGTTACCCGAGCCGCCGATAGCGTTTTCCACGGTCACGCCCTTGGCGATGGAGACGTTGCCCACCAGGCCGCCGACATTGGAGAACGAACCTTCATTGAGGTTGATTTGCTGGGCTTTGCTGAAGCCGGAGAAGTCCAGGGTGTCGTTGCCGCCGCCGTCCCAGACGGCGAACACCAATTTGTCGGTGGCGGAGGTGGCACTCAGGTAATCACGATCGGTGTTGGAGTTGAAGTCGTAAGTGGTGTCTGTGGCGCGGGTGTCGTAGTTGGCGCCGTAGTGCTTCTGGATCGCGGCGATGTCATCGACCAGCGGCCCAGCTGA	MQAGALGDARQVDLVAATGEVEDLVCRPRFGVRAGAKHEGVSPGATPQLIRSATTVEHVIARATLEYVIRGVAHQQVVTRAADSVFHGHALGDGDVAHQAADIGERTFIEVDLLGFAEAGEVQGVVAAAVPDGEHQFVGGGGGTQVITIGVGVEVVSGVCGAGVVVGAVVLLDRGDVIDQRPS	MDYSICDIAESNELILEAAKILRKSFLDAGNESWVDIKKAIEEVEDCIEHPNLCLGICLDDKLIGWTGLRPMYDKTWELHPMVIKTEYQCRGIGKVLIKELEKRAKGRGIIGIALGTDDEYQKTSLSMIDINERNIFDEIGNIKNVTNHPYEFYKKCGYMIVGIIPNANGKRKPDIWMWKDIS	100.00	gnl|BL_ORD_ID|1223|hsp_num:0	1327			87	438	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0001045.1|Spiruchostatin_3 # 1159 # 1323 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.582	BGC0001045.1|Spiruchostatin_3 	1159	1323	+	Loose	750	24.6386	tet(X)	44.44	3000205	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGCCCGATTTCGTGGGTCAGGGTCTGGCGTCCGTAGTTACCGTTAGCCGGGGTGCTGTTGACCTGGTAGTCCTGGCTGATCTTGTACCAGGTTTCGCTGGTGCCGCTGCTGTTTGGATACTCGCCGAAGGCCGCGCCTTTGCTGTCCACCTGGGTAAAAGTTGA	MPDFVGQGLASVVTVSRGAVDLVVLADLVPGFAGAAAVWILAEGRAFAVHLGKS	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV	13.92	gnl|BL_ORD_ID|763|hsp_num:0	776			945	1008	tigecycline; tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0001045.1|Spiruchostatin_4 # 1765 # 2040 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.540	BGC0001045.1|Spiruchostatin_4 	1765	2040	+	Loose	2000	24.6386	Staphylococcus aureus mupA conferring resistance to mupirocin	40.0	3000521	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGACGGCATTTGGTCTCGCCAGGGGCCGAGGTTTCGACGTCCACGGGTTCCCCATCCAGGCTGTTCAGTCACTGAGCGCGCGGCGGACAGCAGGTGCGACCTTGGGGGCAGTGGGCTCTTTGCCGGGGCTGTCATATTCACTGGTTTACTTTGTAACAAATCAATTCATTCTCGCCCAGGTCATTTGCCCCCGATATAGAGGACACGTCAGGCCGGTATCGACAAAACATTCCTGCCCTTTATTCATCTTTGCGCTTGTTATCAAGCAACAGTAA	MTAFGLARGRGFDVHGFPIQAVQSLSARRTAGATLGAVGSLPGLSYSLVYFVTNQFILAQVICPRYRGHVRPVSTKHSCPLFIFALVIKQQ	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	8.89	gnl|BL_ORD_ID|4699|hsp_num:0	2270			201	261	mupirocin
BGC0001045.1|Spiruchostatin_5 # 2309 # 2977 # -1 # ID=1_5;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.580	BGC0001045.1|Spiruchostatin_5 	2309	2977	-	Loose	500	26.5646	CARB-12	28.85	3002250	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	TTGGGTATTACTTTCGCTCCAGTAGCTCATCAGGCTATAGCCGCGTGTGTCCTCGGCATACGTGACATCGTTGTAGGTCGGGCTGCCATTGCCGGCGTTGTAGTTGCCGGGGTGGGACAGGCCCAGGGAGTGACCGATTTCGTGGGTCAGGGTTTGTCGACCGTAGTTGCCGTTGTCCGGTGTGGTGTTGGTCGGGTATTGGTCATTGACCATGTACCAGGACTGGCCGTCACGCGAACCACCGGTTGGCAGGTACGCGAAGGCTGCGCCACCGGCAAAACTGCTGTAGTTGCCAAACGTCAGTTGACCATCGACACCGCCTGGGGCATCGACAAAGGTCACATTGGCCACATCAGACCAAGACTGCAGCGCAAGGACTGCCTGAGCTTTTTGCAGCGCGCTGAACTCGCTGAACGTACCCAGGCCCGGGTTGAAATCCGCAGGCTGGGACGTCAGGAAAGTGTAACTGAGGCTGATTTTTCCGTCCCCGTTCTGATCGTGCCAACTCGCGCCTTTACGCAGCAATTCGTCCGCGGCCTGATCGGCGGTGAACGAAGGCTTGTCGTTCACCAGATCGACCCCGCCACGGTCATACCGATGGCTGAAACCATCGACCTGATCGTAGGCCTTACTGGCCTGGCCGATAGCAGAAAATGCGTTCTCTTTTAG	MGITFAPVAHQAIAACVLGIRDIVVGRAAIAGVVVAGVGQAQGVTDFVGQGLSTVVAVVRCGVGRVLVIDHVPGLAVTRTTGWQVREGCATGKTAVVAKRQLTIDTAWGIDKGHIGHIRPRLQRKDCLSFLQRAELAERTQARVEIRRLGRQESVTEADFSVPVLIVPTRAFTQQFVRGLIGGERRLVVHQIDPATVIPMAETIDLIVGLTGLADSRKCVLF	MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR	77.08	gnl|BL_ORD_ID|1368|hsp_num:0	1486			291	447	
BGC0001045.1|Spiruchostatin_7 # 3754 # 3924 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.491	BGC0001045.1|Spiruchostatin_7 	3754	3924	+	Loose	890	25.409	cpxA	43.33	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATGGCTTCGCTTTTTATGTTTGGGGCGTTTTGCTTCAGGCAACAAGGTCAGTCATTGCAGTCTGGCCAGGTAATGTTGGTCAGGTTGATGTCGTCACTGCCAGCGCTATTCGGATACTCGCCGCAGGCGGAGCCTTTGCTGAAATGGTGGCAGCTCTAAATTTTTAA	MNGFAFYVWGVLLQATRSVIAVWPGNVGQVDVVTASAIRILAAGGAFAEMVAALNF	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	12.25	gnl|BL_ORD_ID|131|hsp_num:0	152			606	696	novobiocin
BGC0001045.1|Spiruchostatin_8 # 4917 # 5789 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.483	BGC0001045.1|Spiruchostatin_8 	4917	5789	+	Loose	550	41.5874	NmcR	23.81	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGAGTCGTCAGTTTGATGTGGCGGTGCTGAAGACCTTTCATGCTGTGGCACGTTTTGGCCGGTTCAAGGATGCAGCAATATATGTCAACCGCAGTGCTTCAGCAGTTACTGTTCAAATTCACAAGCTTGAAGAGCAGGTTGGGCATCGACTATTTCATCGCAACAATAATGTCGTTGAGCTGACCCCGTTTGGGCGCAAGTTGCTCGGGTATACGACCGATTTCTTGGTTGCCCATGACCGGCTAATAACATCCTTAGCTCCACAACGTCTTTTGCTCAAGTTGAGGCTTGGGGTGCCCGATGTCTACGTGGCAAAATTTATGAAAGACCTGCTTCCGACGTTTACTCTGAGTAATCCTATGCTGGAGTTGGAGGTTGAAGCTCGTTCCAGTGGGGAGTTGTTTGATCTCTTCTCACAGCAGATGCTTGATATCACCCTGTTGGTTGCTTCTCAATGCCCGCAGGATGGGGAGTTTCTCTGCTCAACGTCACCCCGCTGGGTTGTTTCACCAGCATTCAAATACGACCCAGGCCAGCCATTGCCCGTTTCTGTACATCTTCATGGTTGCCCATACCGTGAGGCGGCTATTCGAGCGCTCAAGACGGCAGGCATAAAATTTCGAATATTTATGGAAAGTTCTAGTTTTACTGCCGTTGAAGCTTCAGTGATGAGCGGATTGTCCATCGGGGTGATGGAAAATGGTTTAGTCGATCGGCGGGCCAACAGGAGTGTGCAGGGAATCGAGCTTCCCGACTTGGATGAGCATTTCATATGTTTATTAACGAACAGTAATAGTCCTGCGGCGGTGTCCTTGAGAAATGCTATTTTTGAGCAATTTTCCAAGAGTGAGTTTTTGCTGGATGTCGTATAG	MSRQFDVAVLKTFHAVARFGRFKDAAIYVNRSASAVTVQIHKLEEQVGHRLFHRNNNVVELTPFGRKLLGYTTDFLVAHDRLITSLAPQRLLLKLRLGVPDVYVAKFMKDLLPTFTLSNPMLELEVEARSSGELFDLFSQQMLDITLLVASQCPQDGEFLCSTSPRWVVSPAFKYDPGQPLPVSVHLHGCPYREAAIRALKTAGIKFRIFMESSSFTAVEASVMSGLSIGVMENGLVDRRANRSVQGIELPDLDEHFICLLTNSNSPAAVSLRNAIFEQFSKSEFLLDVV	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	98.31	gnl|BL_ORD_ID|1905|hsp_num:0	2072			0	378	cefoxitin; cefazolin; ampicillin
BGC0001045.1|Spiruchostatin_9 # 6311 # 6634 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.426	BGC0001045.1|Spiruchostatin_9 	6311	6634	+	Loose	550	23.8682	FONA-5	36.11	3004792	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FONA beta-lactamase	ATGCAATCAGTTCAGGTTAGGGAGCGCAGAAAAGTATCAAGATCTGTGAAGTATTTATTGCCTTTTTGGGGAGGGGCTCGACTACTTGTGGTATTTGAATTGGATAGATTTAGATCCTCCTATTGGCCCAGTCAGGTGCGGGAGAGCGCTGACTCTATCCTTGTTGAATTAAATGCTCGTCGATCTATATCGGGTTCTGGGGATAATCAAATAACGAACGAAGTTTTAGTTGTTTTTACTGCCCTGACTAGAGCAGTAAAGCTGCTTCTTTCGACTTGTTTTTGGCTATCCAGACAAATAACTAAACGTGAGGCGCAGTTATGA	MQSVQVRERRKVSRSVKYLLPFWGGARLLVVFELDRFRSSYWPSQVRESADSILVELNARRSISGSGDNQITNEVLVVFTALTRAVKLLLSTCFWLSRQITKREAQL	MVRNTLRQTTLMVATVMPLLFGSAPLWAQPANAKANIQQQLSELEKNSGGRLGVALIDTADNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPQAMAISLQNLTLGKALAEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL	36.27	gnl|BL_ORD_ID|2304|hsp_num:0	3589			723	825	
BGC0001045.1|Spiruchostatin_10 # 6631 # 11655 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.566	BGC0001045.1|Spiruchostatin_10 	6631	11655	+	Loose	1000	133.65	almE	31.94	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAACCCCCCTTACAACGAACAACCTCGTGTTCTACCTCGTCTTTCTCTGTCAGAGCAATTGATGTTACGCGCCGATGCCTTCCCGGACCTTCTGGCATTCGCTTCGCTGGATCAATCGAAGGGTGTCTCGCTGACAAATGCAGACCTGTGTGAACGTGCAGCCGCTATTGCGTATCGCCTGGCAAAATGCACCTCGCCCGGCGATCGCGTATTGCTGTCTTATGACCATCCTCTTGATTTTATTCCGGCATTTTTTGGTTGTTGTTTCTCCGGCACGATTGCCGTCCCCGTTGCCCCTCGAACCAATGGAGAAACCGTAGCGGCTATCCTTCTGGATTGCGGTGCGACAATTGCACTGACTGCGCAAGGGGGTAAGGAGTCTTCCGGTATTGACTGGCTACAAACAGACGACAACGAGCGGCGTGCTTCTTTTATGCGTTTGGCTGACGAAAATAATCCTGCGTTGCTCCAGTACACGTCCGGCTCCACACGAACACCGCGAGGCGTTGCTGTAACCCAGGCGAGCCTTCGCACAACGATCGAAGACCTCGACCGTGCAGCCCTGCACGATGCTCAGAGCGTGATGGTGAGCTGGTTGCCGTACTTCCATGACATGGGCCTGGTGTACGGCATTCTCACACCCTTGTATTGCGGTTTCAGCGCTTACTTGATGCCTCCGGAGAGTTTCATTGCACAGCCCTTATCGTGGTTGCGGGCGATAGCGGCTGTACGCGGTACTCATACGGCAGCCCCCAACTTTGCCTATGCCTTGTGCGCGGATCGGGCTGCTGATCTGCTACCAGGAACCGATCTGTCTTCGCTACGATTCGCGCTCAATGGTGCAGAGCCGATTAGGTGTGACAGCGTCCGTCGATTCGAAGCAGCCTTTGCTCCCTTCGGAATGTCGTCCTCAGTGGTCATACCTGGATATGGTTTGGCAGAGGCGACCTTGAAGGTGACATCCGGGCGTTGCGGTGAAGGTACCCGCAGTAGACATTTCGAACCTGATGCGCTGGCGGTTGGGAAGGTTGTTCCCTGCCACCAAGGCGTTGAGCTGGCGTCATGCGGTACTAGCTCGGTGGGGGCAAGCATTTTGATTGTCGACCCTGCCACTCTTGTTCCTTGCAAACCGGATGTGATCGGTGAAATTTGGGTTGCGGGGCAAAGTGTTGCGGATGGTTATTGGTCCCGTGAGCACGAAACACTGGAGATATTCCAAGCCTGCCTTGCTGCTGGAGGAGGCCCATGGCTTCGTACCGGTGATCTCGGTTTTCTTCAGCAAGACGAGCTCTTTGTCGTGGGCCGACTGAAGGATCTGATCATTGTCGGGGGGCGTAATATCTACTGTTACGACTTGGAGGACTCGGTCTCTGAATGTCACTCGGATATTCGCAAAGGCCGGGTATTCGCTGTCGCTGTAGAAGGTGAGGATGGCGAGGAGGTTCTCATCGGTGCCGAGGTGCGTAGTAGCTGCAAAGAGGGTGATACACGGGCCATCCTTGCGCGTATCCGCACTGAGTTAAAGACCCGGCATGACGTAGGTGCCGTGCGTATCGTGTTGCTTAAGCGAGGGAGCATTCTTCGCACATCAAGTGGTAAGACCCGTCGTGCGGCAACACGCGATGCTCTTTTTCGCGGTGAGTTGCAAGTCATCGCAGACTCCAATGGCCAATCAGCCGAAGTTGACGACGACATCCTTTTGCAAATTGCTCGTTTTGTGCCGGGTGCTGTGAGCGAGCCCACCAGTAGGCTCATTGATGCTGGGCTCGACTCGCTTTCAGCGGCTCGGCTGGCAGCGGCCATTTACTCGCGTTACGGTGTAAGGCTCAAGTTTGAGACGTTGTGCGCGGCATCGGTCGATAGTCTGCGCAGGGACATTGCCAATGCACAAAGTGTTGCGGTCGCAGAGTCTTTAGCTTCGTACTCTATCGATTTCACAAGGCCGTTTGAACTGTCCGAAATGCAGCAAGCCTATTGGATTGGTCAGCAGAGCGGTGTTCCCCTGGGCAGTGTTCGGCCACATATTCGTGTCGATTTTGAAGTCGATCACGCTCAGGTACCCTCTCTGAGTCTGAGGCTGGCGGCGCTTGTGACGGCTCATCCGGCTTTGCGGATGTCCGTGCAAGAGGATGGGCGTGGGATCATTGATCGGCACGGGTACGACCCCATTATCGGTCATAGAGACTTGCGCGGTCTTGCGCAACAAAACCTCGCCGAGGCCTTGAGCGCTGTGCGTGACGAACTCGCTCAGGACAATCGTCAGGCCCTCAGCGCTTGCTTCACGCGCCTTACTGATACCAACACGCTGTTGCATTTACGCTTGGGGTTGCTCGCTGGCGATTTGCGAAGCGTGCTGCTCCTTGTTCGGGAACTAGTCAACGGTCCTTCCCTGGCGCCGGGTTTCTGGGGCATGGAGAGGCGCACTTCGCCTATGCCGCTAGATGTTCGCGAAGCCTGGCTGAGAAAGGTGGCGTCAATCGCGCCGGCCCCCGATTTACCGCAGGCAATGGCCGCCAGCGATGTTGATACTCCCCGTTTTGTCACGTGCCACCAGGAGCTATCGCAAGAGCTGACAACCGCGCTGGCATTAAATGCGCAGGCACTAGGAGTCACGCTCTCGTCAATCTGCATGGCGGCATTTGTTGATGTCTTGCGTTTATGGTCAACCTCGCCAGAACTGACCATTAATGTGACCTGCAGCACACGATCAGGTTTGACCGAACAGGCCATTGGCGACTTTACGAGCAGTATCCTGCTGTCTTTGTGCGAGTCCCACGGCTCCTTCGCCGACTTGTCTCGGGCAATCCAGCAACAGGTATGGCGTGAGCTGGATGATCCTTGTTCCACAGGTATTTCGATGCTTCGCGAGCTCAGTCGCCGCAACGGCTCACCGGTTCTGATGCCGATAGTCTTGACCAGCCTTCTGTCGGGAGACCCAGCCGACGACCTCTCGGTCCTTGATTCAATCGGGCTTATGGTCAACGTCTCCAATCCGACCCCGCAAGTATCACTGCACAACATCCTGGCGCGACGCGACGGGTGTTTGATGATGATGTGGGAGTACGTCGAACAGTTGTTTCCTGCCGGAATGATCGAGGCAATGTTCGCATCGTTTGTGGACGTGCTCACGATGATCGCCCACACACCCTCTGCAGTCGAATACCCCGTACTGGCTAAGCTTCCAGCCGTTCAGCACGCTCGGCACTTAAAGGCGAACTCGACGAATCGCGACAGGTCCCCGCGTCGATTGTCTACGCCGTTTATAGAGCGCGCCACCGAAACCCCGGACGCGATCGCGGTGATATTCGGTGATCAAATCACCACCTACGGTGACTTACTGCAGGATGCCGAGGACATCGCCGCTAGATTGCAACGTAAAGGCGTCAGCCGTGGAGATATTATTGCGGCCATTGTCGAACCAGGTCCCAGGGCCGTGGCAGCACTGATTGGGATTGGAATCGCTGGAGCGGTCTATCTCCCAATTGAGCCGTCTTGGCCGCTGACGAGAATTGAAGAGCTGTTGTACGAATCCAAGGCCGGGTATGCGGTGGTGATGCACAGCATGGACCTGCCGATACCGATGCTGCAGCTTGATGAGAAACCGGGTCGGCTCCGGCCTGAGCCGGTGGGTGGTGCGCCAAGCGATGTGGCGTATGTGATTTTCACCTCTGGTTCGACGGGGCGCCCCAAAGGCGTGGTTATTACCCATGAGGCTGCGGCGAACACCATAGACGACATCAATGAGCGCTTCTCGGTCGGCCCTGCGGATCGAGCATTGTGTGTCTCATCACTGGCGTTTGACCTTTCTGTCTACGACATTTTCGGGTTGCTTGCGGTAGGCGGCGCGGTGGTTTTCCCGGAGCGATTGCGAGATCCGGACGCGATTGCGCAAGCATTGACGGCTGCTGGTGTAACCATTTGGAACTCGGTACCTGCAGTCCTTGAATTGTTGCTTGATGTCGCTGCGCCTCATTCGTCCACTTTACGACTCGTCTTGCTCAGTGGCGATTGGATTGCACCGGCGTTTACGGCGCGTATCCGTCAGGTGTTTACCCAGGCCGAGCCCATCAGCCTGGGGGGCGCAACAGAGGTTTCGATCTGGTCAGTCATTCACCCCATTGTTCCTGGCGACGCGGCACGGGTCTCAATTCCATATGGCGCACCGCTCTCAAATCAACAGTGTTTTGTGCGGGCCCCTGACGGACGTGAGCGCCCTGATGGCGTGGCTGGAGAGTTGCTGTTGGGTGGACGAGGCCTGGCCCAGGCTTATTGCGGCAACGATGCAGAAACCAACCGGCGCTTTTTCACCGATCAGGATGGCAATCGGCTCTATCGGACTGGCGATCTTGCACGATGGATGGCGACTGGCGAACTTGAACTGCTTGGACGTATGGACGATCAAGTCAAGGTTCAAGGGTACCGCATCGAACTGGGTGAAATTGAAGCTGTAGCGATGAAAGCCGGTGGTATTTCACGGGCTGTGGCCTCGGTCGTTCGACGCAGGGGAGCGACGGTAATCCAGCTTCATGTGCTTGTGTCGCAGGGAATGCCCGGCGAGGTTGTGACTTCAGTGCGTGCGGCACTGGCTCATCATCTCCCGGCCTATATGCAACCGCATCATGTGGGGGTACTCGACACTCTCCCTTTGACGGCGAACGGCAAGGTGGATCGCTCACGGTTGCCAGCGCCACCTGAGCCGAGGGCCGCCTTGCCGATGCGCGGCGACGTTCTGCTCGAAACGATGATGATGCAGGCTTATGTCGAAGTGGTGGGTATTGGCATTGATCCTCAGCAGCGGTTCTTCGATGCGGGAGCGACTTCATTGCACATCGTGCGTTTGCGCGCACTGCTGGAGTCTCGTGGGATAGCGATTCCGTCGCTGGCTGACTTCTTCTCGCTTGCGACTATTCGATCAATTGCCACCTCCTCCATGGAGGGTGTCAGTGCCAACTCCAATCAGAACGATATTGCTTGCATGCGCGCTTACAAGCAACGCCTGCGAGCGCGCAGGGGAGAATTGTAA	MNPPYNEQPRVLPRLSLSEQLMLRADAFPDLLAFASLDQSKGVSLTNADLCERAAAIAYRLAKCTSPGDRVLLSYDHPLDFIPAFFGCCFSGTIAVPVAPRTNGETVAAILLDCGATIALTAQGGKESSGIDWLQTDDNERRASFMRLADENNPALLQYTSGSTRTPRGVAVTQASLRTTIEDLDRAALHDAQSVMVSWLPYFHDMGLVYGILTPLYCGFSAYLMPPESFIAQPLSWLRAIAAVRGTHTAAPNFAYALCADRAADLLPGTDLSSLRFALNGAEPIRCDSVRRFEAAFAPFGMSSSVVIPGYGLAEATLKVTSGRCGEGTRSRHFEPDALAVGKVVPCHQGVELASCGTSSVGASILIVDPATLVPCKPDVIGEIWVAGQSVADGYWSREHETLEIFQACLAAGGGPWLRTGDLGFLQQDELFVVGRLKDLIIVGGRNIYCYDLEDSVSECHSDIRKGRVFAVAVEGEDGEEVLIGAEVRSSCKEGDTRAILARIRTELKTRHDVGAVRIVLLKRGSILRTSSGKTRRAATRDALFRGELQVIADSNGQSAEVDDDILLQIARFVPGAVSEPTSRLIDAGLDSLSAARLAAAIYSRYGVRLKFETLCAASVDSLRRDIANAQSVAVAESLASYSIDFTRPFELSEMQQAYWIGQQSGVPLGSVRPHIRVDFEVDHAQVPSLSLRLAALVTAHPALRMSVQEDGRGIIDRHGYDPIIGHRDLRGLAQQNLAEALSAVRDELAQDNRQALSACFTRLTDTNTLLHLRLGLLAGDLRSVLLLVRELVNGPSLAPGFWGMERRTSPMPLDVREAWLRKVASIAPAPDLPQAMAASDVDTPRFVTCHQELSQELTTALALNAQALGVTLSSICMAAFVDVLRLWSTSPELTINVTCSTRSGLTEQAIGDFTSSILLSLCESHGSFADLSRAIQQQVWRELDDPCSTGISMLRELSRRNGSPVLMPIVLTSLLSGDPADDLSVLDSIGLMVNVSNPTPQVSLHNILARRDGCLMMMWEYVEQLFPAGMIEAMFASFVDVLTMIAHTPSAVEYPVLAKLPAVQHARHLKANSTNRDRSPRRLSTPFIERATETPDAIAVIFGDQITTYGDLLQDAEDIAARLQRKGVSRGDIIAAIVEPGPRAVAALIGIGIAGAVYLPIEPSWPLTRIEELLYESKAGYAVVMHSMDLPIPMLQLDEKPGRLRPEPVGGAPSDVAYVIFTSGSTGRPKGVVITHEAAANTIDDINERFSVGPADRALCVSSLAFDLSVYDIFGLLAVGGAVVFPERLRDPDAIAQALTAAGVTIWNSVPAVLELLLDVAAPHSSTLRLVLLSGDWIAPAFTARIRQVFTQAEPISLGGATEVSIWSVIHPIVPGDAARVSIPYGAPLSNQQCFVRAPDGRERPDGVAGELLLGGRGLAQAYCGNDAETNRRFFTDQDGNRLYRTGDLARWMATGELELLGRMDDQVKVQGYRIELGEIEAVAMKAGGISRAVASVVRRRGATVIQLHVLVSQGMPGEVVTSVRAALAHHLPAYMQPHHVGVLDTLPLTANGKVDRSRLPAPPEPRAALPMRGDVLLETMMMQAYVEVVGIGIDPQQRFFDAGATSLHIVRLRALLESRGIAIPSLADFFSLATIRSIATSSMEGVSANSNQNDIACMRAYKQRLRARRGEL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	301.08	gnl|BL_ORD_ID|4935|hsp_num:0	5928			582	1617	colistin A; colistin B
BGC0001045.1|Spiruchostatin_11 # 11655 # 16340 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.585	BGC0001045.1|Spiruchostatin_11 	11655	16340	+	Loose	500	28.8758	OXA-542	28.57	3005768	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGACCAGGATATACCTGTTGATGCCGTAGCAATCATTGGTGCCGGCTGCCGGGTTCCGGGGGCAACCACATTGGAACAGTTCTGGTCGGTTATCGCCGGCGCAGAGGTGACGATTGAGCGCTTCAGCGCGGACGTTGCAAGGCGCGAGGGGGTGCCCGAGACGGTATTGTCCCAACCCGGTTTTATCGGGGCGGGAGGCGCTCTTGAAAATATTGAGATGTTCGATGCGGCGTTGTTTGGGATTGCGCCTTCCCAAGCAGCCTGTATGGACCCTCAACAACGCGTCTTTCTTGAATGCGTTCATGACGCGCTGGAACACGCCGGGCACGGTGCGGCTCGAGGTCCACGCGTGGGTATCTGGGCAGGTTCTGCGAGCCTTGATTATTTGGCTGACCATGTCTTGGGCCAGTTGGATCGCTCATCGCCGAACCGCTATTTGCAACAATGGGTCGGTGTTGACAAAGATTACCTGGCTGCACAAGTGGCGTACCGCATGGATTTTGGTGGCCCGGCAATCACGGTACAGACTGCCTGTTCCACTTCTCTGGTTGCCGTCGCACTCGCGGTTCAAGGATTGTTGAATTACCAATGCGACGTCGCCGTGGCGGGAGGTGTCAGTATTGGATTACCGCAACGGCAGGGATATGTGCATGAGGACGGTAGTATTCTCGCCGCCGATGGTGCATGTCGCCCCTTCACTACACAAAGTAGCGGCACTGTGTTTGGCAACGGCGCTGGTGCGGTGGTCTTGCGGCGCCTGGAGGATGCGCTTGACGATGGGGACACTATTCTGGCGGTGATTCGTGGTGCAGCGATTAACAATGATGGGGCCGCCAAAGTAGGTTTTACCGCACCTGGAGGCCGGGGGCAGGGGGATGTGATCCGCACAGCCCTTCAGCTCGGTGAAGTTGACGGGGCTTCGATCGGGTATGTGGAGACACATGGTACAGGGACTGCCATTGGGGATGCGGTGGAGCTTTCGGCGTTGATGAGCGCATTAGGGGATCGACAGCTTGATGGGCAGCGTTGTGCTATTGGTTCGGTCAAGGCGAACGTCGGGCATATGAATGCAGCGGCAGGCGTGTGTGGTTTGATCAAAGTCGCACTCGCCGTTCAGCATGCGCAGATTCCGCCGACAGTGGGGGCCGCGCACGCCATCGACGCGTTACGTGAAGGATCTCCTTATTACCTGCCAACTGACCTGACGCCTTGGAGTAGCCCGGATCGGCGGGCGGGAGTCAGTTCGTTCGGTATTGGTGGTACCAATGCCCACGTGATCCTGGAAGCATCACCTCGTCGTCTGGCGCGGGTGCGCAGCACCGTACCCCTGCTGCTGGTTTCGGCGCGTGAAGATGCCTTACGCGATCTGTGCGCAAACTATGCGGCGTTCTTGGAGGCGGACCCAGATCTATCTATCGAGGATGTGTGTTTTACGGCAGCTGTTGGAAGGCTACCCAGGGAGCGGCGTGTGGCTTTTCGCGCTGAGCACCGTGGCCAACTGATCAGTTCGTTGAAGGCTTTTGCTGAAGGCAGACAAGATGCGAACGCATTTTTTTACGAAGAGCAGGAGCGTCGACCTGAGGTCACATTCGCCTTTGGCGATACCGATAATCTAGGTGCGGCTATCGACGGCGCTTTAGTCTGGCAGGCGCGCGGTGTTGTACCCTCGGTTGTCTGCGGTACTGGAGCCGGCCTGTTTGCAGCAGCCTTTGCGGCAGGTGCCTTGAGCGCTGAGGATGCGCGCAGTGCTCAGGCGCACAATGCGGTGGCACCGTCACTGCTTTGGATCAGTGCATTCTCGGGTATGGCAATTGATAGCGTGGAGGCTGTGCGTAAGGAACTTGCACAGGTCGCGCAGAGTGGGGGGGATGGTGCTTCGGCGGTGGCGGCAACCGGAGCGACGCGGGTGCTTGAGTTCGGTGACAACGCGCTAGGTGCTGATGTAGCTGGTGTCGTTTCATTCGCCCAGGGGGCGCTCGATGCGATTGCGGGGCTCTGGACCAGCGGTATCGATCTGGATTTGACGAAAATCTACAGCGGCGCAAATCGCGTGTCGCTTCCAACCTATCCGTTCCAGCGTAAGCGTTTCTGGATTGACCGCGCGCCCCGTTACACAGATAGCGGCACTTCAATTTTTCTTGGGCGGCGCACAGAGGCGCCAATGCTGCGAGCCAGCTTCTTTGATGCCCAATGGAGCGTGGCGACCCTGCCATTTCTCAGTGATCACATGATTTACGGAAAGGTCATCGTCTCCGGTGCGGCGCTGGCGGTGATGATCGCTGAAGGGGTGCGCGAGGTGAGTAAAGCGCATGAATTTGCTCTGCACGATCTACGTTTCCCCGCTGCCCTGGTGATTCCGCAAGGCATGGGGCGTCGGGTGCAACTGCAACTTGTACGTGATGATGATGGTTTTGACGCGACCGTGTTGACCCAGGATCCCTTCGAAATCCACGCCACGGCCCGGGTCGAAACGACCACAACGGTCAGTGTCGTGCCGTCGCAGGAGGTGCAAGGAATAGACACCCCAACCGCCTTGCTGGACTCGTGGTTACGCGACCACGGCGTGGTAATGGGGCCTTCGTTCAGTCGGCTATCGGACATTGTCATCGGTCATAACGATGCCGTCTGTTCGATGCGCACCGATGCTGGCGATGACGGGTGGCTGCTTCACCCAGGGATCCTCGATTCGGCCCTGCAACTCGTGGCGGTTGCCGCTAGGCCGGAAGGGAGCAAGGCGTTTGTTCCCACCCGTATCGCTCGGTTGACCATACGTGCCCATACCGCGTCGCAGGTTCGTTGCTATGCCGCGGCCGATCGGGGCCTCGCCACGCTGTTTGACGACCACGGCGTTTTGGCCGAACTGGTGGGCCTGGAGTCGCGTGATGTCAGCCGGAACGAACTGCTGCGTATCGACCCGCTGCGCGATGGCTACTCCATCGAATGGCGGAGCTCGTCGCTTGATCGGTCGTTTGAATTGCCACAGACCGTCGTCGTTATTCGGGATGCGGACGGGGTTGCCGAGGAGCTGGCTGCGATCCTGCAGGCTGAGGGCAAGCGTCCCCTTGTTGTCGGCAGCCCCTCTGATATTTCGTTTGAGACAACCGACTTTGTTGTTGATTGCCGTGGGTCAGATGCACGTTCGACGGCACCCGACCTGAGTGTGTATGAGGGGGCTTTGGACTTGCTTGGTACCGTGGCGAGAAAGGACCTCCCGTGTTGTGTAGCTATCGTCCTGCCGGTGAATGTACCCAGTGGGGCACCGCTTCAGGCACTTGCTCGGGTGGCGGCTATGGAAACTCCCTACCTTCGCACCTTGGCGGTACGCGCCAACAATGCGCAAAGCATTCGTCGCGGCCTCGACTTTTTTGATCAAGAAACAGAAGTCATGGTCGATGGGGATAACATTTCGGCGCCGCGTTTCCAGCGATTTGATCTTCCGCGGCGTACTGAGTCGAGTTTTTCGGGCGACGAAACGTGGCTCATTACCGGTGGCCTTGGTGAACTGGGTTTACGTGTTGCGAGCTGGCTCAGCGCGCTCGGGGTTCGGTCATTGGTACTCACCGGCCGACACTCACCTGATACGAATGCCCAGGAAACACTGACTGTATTTGGGCATGAAGGCATTAACGTTCAAGTGATTCAGGCTGACTTGTCAAGCGAGGCAGACATTGAGGCGTTGTTGCACAAGATCGATACGACGATGCCGGCTTTGCGCGGGATCTGTCACTTGGCCGGCGTGGTCGAGGATCGACTCATGGGCGATGTCACACCCGCATCGCTGAAAACGACGTTTGCCGGTAAAGCTGAGGGGGCATGGTTGCTGCACGAGCGGACACTGCATTACCCACTCAAGCATTTCATTTTATTCTCATCTGCTGCCGCGGCGTTTGGTGCGCCAGGGCAGGCGGCGTACGCGATGGCCAATGCCTATCTGGATGAGCTTGCAGTCTATCGCCGGTCACTGGGGTTGCCGGCGCTGTCGATCGCTTGGGGTCCGTGGCAAGACATTGGTATGGCTGCTCGTACTGCTGTCACCGCGAAACGCCGGTTGAGTCAGTTGGGTATCGGCCAGATAGAGGAGGAGTGCGGTCGTGCGACGTTCGAGAACATCCTGTTTGCCGATCTGCCCGCGCACTGCGTCCTGCTTGCGGTCGATTGGCAGCGTCTGGTCGGACAGTGGCCGCCCCAGGTGCCATTCAGTCGTTTTGACGACATTGTCAGCGATATTCCTGGCTCTGCGAGAACGTTGTCGGTCAATGAGTTGCTCCCACTGTCTCCCGATGAACGACGGCATCGGTTGTTCCAGCTGATTGCCGAGGATGTGTCATCCATCACGGGGACAGACTTGGCGACGCTCGATCCGGAACGTTCGTTGTTTGAGTACGATCTTGACTCGTTGCTCATTACAGACCTGCGTTTGAAGTTCGAGAGGCGATTCGGTCGCCCGGTTGCGGCAACGGTTATTTTCTCTAACCCTACGGTCGCGGCGCTGGCCGACCATATGGCGCAGACGATCTTTGGTGAGGTGCCAACTGACGTATTGCGCAGCGTGGCTGATCAAGCTCCGCTGCCTGTGGCAGTGCTCACTGAGCCAGACAATTCAAGACCTGAACAGCTATCCCAGGAAGATGTTGTCGAAATGCTGTCGGCGAAGCTCGAAGAGCTTCGTGGAGGGCGCTCGTGA	MDQDIPVDAVAIIGAGCRVPGATTLEQFWSVIAGAEVTIERFSADVARREGVPETVLSQPGFIGAGGALENIEMFDAALFGIAPSQAACMDPQQRVFLECVHDALEHAGHGAARGPRVGIWAGSASLDYLADHVLGQLDRSSPNRYLQQWVGVDKDYLAAQVAYRMDFGGPAITVQTACSTSLVAVALAVQGLLNYQCDVAVAGGVSIGLPQRQGYVHEDGSILAADGACRPFTTQSSGTVFGNGAGAVVLRRLEDALDDGDTILAVIRGAAINNDGAAKVGFTAPGGRGQGDVIRTALQLGEVDGASIGYVETHGTGTAIGDAVELSALMSALGDRQLDGQRCAIGSVKANVGHMNAAAGVCGLIKVALAVQHAQIPPTVGAAHAIDALREGSPYYLPTDLTPWSSPDRRAGVSSFGIGGTNAHVILEASPRRLARVRSTVPLLLVSAREDALRDLCANYAAFLEADPDLSIEDVCFTAAVGRLPRERRVAFRAEHRGQLISSLKAFAEGRQDANAFFYEEQERRPEVTFAFGDTDNLGAAIDGALVWQARGVVPSVVCGTGAGLFAAAFAAGALSAEDARSAQAHNAVAPSLLWISAFSGMAIDSVEAVRKELAQVAQSGGDGASAVAATGATRVLEFGDNALGADVAGVVSFAQGALDAIAGLWTSGIDLDLTKIYSGANRVSLPTYPFQRKRFWIDRAPRYTDSGTSIFLGRRTEAPMLRASFFDAQWSVATLPFLSDHMIYGKVIVSGAALAVMIAEGVREVSKAHEFALHDLRFPAALVIPQGMGRRVQLQLVRDDDGFDATVLTQDPFEIHATARVETTTTVSVVPSQEVQGIDTPTALLDSWLRDHGVVMGPSFSRLSDIVIGHNDAVCSMRTDAGDDGWLLHPGILDSALQLVAVAARPEGSKAFVPTRIARLTIRAHTASQVRCYAAADRGLATLFDDHGVLAELVGLESRDVSRNELLRIDPLRDGYSIEWRSSSLDRSFELPQTVVVIRDADGVAEELAAILQAEGKRPLVVGSPSDISFETTDFVVDCRGSDARSTAPDLSVYEGALDLLGTVARKDLPCCVAIVLPVNVPSGAPLQALARVAAMETPYLRTLAVRANNAQSIRRGLDFFDQETEVMVDGDNISAPRFQRFDLPRRTESSFSGDETWLITGGLGELGLRVASWLSALGVRSLVLTGRHSPDTNAQETLTVFGHEGINVQVIQADLSSEADIEALLHKIDTTMPALRGICHLAGVVEDRLMGDVTPASLKTTFAGKAEGAWLLHERTLHYPLKHFILFSSAAAAFGAPGQAAYAMANAYLDELAVYRRSLGLPALSIAWGPWQDIGMAARTAVTAKRRLSQLGIGQIEEECGRATFENILFADLPAHCVLLAVDWQRLVGQWPPQVPFSRFDDIVSDIPGSARTLSVNELLPLSPDERRHRLFQLIAEDVSSITGTDLATLDPERSLFEYDLDSLLITDLRLKFERRFGRPVAATVIFSNPTVAALADHMAQTIFGEVPTDVLRSVADQAPLPVAVLTEPDNSRPEQLSQEDVVEMLSAKLEELRGGRS	MKKVVFPILSIFTLFSLNACSSVQTASESTISAYNQQSKETIKKYFDDAQTQGVIVIKDNNHLAIYGNNLTRAHTQYVPASTFKMLNALIGLENNKVTTDELFKWDGNKKAFPIWEKDMNLDEAMKLSAVPVYQELAKRIGIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEVKFADDLAHNKLPFKIETQETVKNMLLIKEINGSKIYAKSGWGMDVTPQVGWLTGWVEQPTGKIISFSLNLEMKNNMTGSIRNEITYKALENLGII	567.64	gnl|BL_ORD_ID|3803|hsp_num:0	4873			252	453	cloxacillin; oxacillin; cefalotin
BGC0001045.1|Spiruchostatin_13 # 19864 # 32109 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=11bp;gc_cont=0.585	BGC0001045.1|Spiruchostatin_13 	19864	32109	+	Loose	1000	135.961	almE	27.16	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACTATCGCACAACTCTTGGCCGACCTTGCGGATGTGGGCGTTACCCTGCGTCGTTGTGGTGAGCAACTTGAAGTGGAGGGCCCTACCGGTAGTCTGGGCCCCGATTTGCTTGAGCGTCTGCGTCAATCGAAACAAGCGCTGTTGCAAATGATCCAGGACGAGAACGCCCTGTTGACGAAAATGCCACTGCCAGTTCCCGGCGAAGGCACAGAAGCCTGCGAGCTTTCCCTTGGCCAACAACGGCTGGTAGTGGCCACGCAGCTTGGAGAACCTACGATCTACAACGAGCAGGCCGCGATTGAGTTCGCTGCCGATGTTGATGTGCTGGCGATCACTGAAGCTTTTGCAGCACTGGCGCACAAACACGACATCCTGCACACGGTATTTACTGACGATGAGCCCTCACAGCAAACCGTGATTGCCGACGCGCGAGTTCCACTTCAATCCTGGGAGGTGCGCAGTAACGACGAATTGCACACGTTGGCTCGGTCTATCGCTCAAATACCGTTTGTCAACGGAAAGCTGCTTTGGCGGGTTGATCTCTTCTACAAAGCCACAGGCTCGGTGGTACTCGTTCTGACGATTCATCATGCCATTTTTGATCGCTGGACGATGATGTTGCTCATTCGAGACTTCAGCCAATTCCTTCAGCATCCCAGTCATGTGAATGTAGCCCAGGCTGCATCACTGACGTATCGTGATTTTTCAGTCTGGCAACGTCGCTGGATGGATACGCCTGAATATGCTGCGCAATTGGATTGGTGGAAGGACTTGCTGTCGGGCATCGATAGTTTTCCGGTGATTCAGGGCGACCGTCCTCCTCCTGCGGTGCCGAGCGGGCGCGGAGCTACCGAACGCATGAAGATCCCTGCCGACTGTATCCGTGCGGCGTCAGAGTTTTCACGCCAGCAAAACACCACACTGTTCTCCACTCTGCTCAGTATCTTTCAGTTGCTGCACCACCGTTATACCGGTGAGTCTCAGGTACTGACGCTGGCGCCTGTTGCCAGCAGGCCCTTTCAGGAAGCTGAAGAGATAGCCGGCTTTTTCGTTAACTTGGTTGCGATCGTAGGGCGTGTCTACAAAGACGATACGTTTCATTCGTTGGTTGAGCGAACCCGAGGTATCACTACCCAGGCGTTTTCTCACCAGTTTGTACCGTTCGATGCGGTGGTAGAACACTTGCGCCAGACGCGAGGCCCCAGATCTGACCAACTGGCCCATGTGGTCTTCGCCCTGCAAAACGTCAACCTTCCCACTGTCCGGGTTGAAGGTGTAGACGCGAAACCGTTCGATCTTGACAGCCCTTTCGCGCGTTTCGATCTTTACCTGTCGATTGAGGGAGATGAGCGTGGCATGTTTGCCGTATGGCAATACAGCCAGGATTTGTTTGATGCCTCTACGATACGCAAGATGGGTGAGCATTACGTCTCGTTGTTACGTGGGGTACTCGCGGCCCCCGAGGCTCCCTTGCAGTCTCTGCCCATGTACAGCGACGTCGAATATGCACAATTGCAGGCCTGGAGCAGGCATGAGCAGCCCTATCGCGCTGATGCAACGGTTGTGGCGTTGTTCCGGGAGCAGGCGGCTGCCCATCCAGAGCAAACAGCTTTGGAGCAGGGAACCGAGTGTTGGACCTATGCACAACTTGAGCGCTGGTCTGACCGTGCGGCGGCAGTGTTACGCAGCGCCGGTGCGGGTCGTGGTTCGATAATCGGTGTGACCGGTGAGCGTTCGCCGCGACTGATTGCAGCCTTTCTGGCTTGCTTGAAGGCCGGTGGCGCGTACTTGCCGCTAGAGCGGAACTACCCGGACGCGCGGCTGAGCGAAATGGTGGCCGATGCCGAGCCTGCGCTGATATTGGTGGCCGATGACCTGGAGCCTGGCTGGCTGAGTAGCTACCCGGGGCCAGTGTTGAAACTGTCGGCCTGCGAGGCCGAACTCCCATTCCCTTCGACGCTGGAATCGGGTGCCGGCGACCTTGCGTATGTCATGTACACATCCGGTTCGACCGGAAAGCCCAAGGGTGTCTGTATCGAGCATCGAGGCATCGTGCGACTGGCCACAGGGGCCGGCTTCATGCAGCTGGACACTTCGACGGTCATGCTGCAAGCCTCATCACTTGGGTTCGATACCTCAACCTTCGAAATTTGGGGCTGCCTGCTTAACGGCGGTCGACTCGTACTGGTTGAGCAGGGGCCGCTGATACTTGAGGCGATGGCCGACACCATTGTAAGCAAAGGCGTGACCTGTGCTTGGCTTACAGCGGACCTGTTTCGACTCATGGTTGAGGAACAAGTCGCCTCCCTGAGGGGGCTGCGCGAATTGCTGGCAGGGGGGGATGCGTTGCCAGTTGCCAGTTGCAAGGCCTTCCTCGAGGCGTGCCCCGACGTGGCGTTGATCAATGGTTATGGCCCTACCGAGAACACTACGTTCACGTCTACGCATCGGGTCACCCAGGAGGATGTACATCGGGTATCGATCCCCATCGGCCGACCATTGGGCAACACTCAGGTATGGGTGGTGAACGAGAACGGTTGCCCTGTACCTCCGGGTGTTCCGGGGGAGTTGTGGACCAGTGGTGATGGTCTGGCGCGTGGTTATCTGGGGCGGGAAGACTTGACTGTGGAGCGGTTCGTCCAAGGACCATTATTGGGGGGGGGGCGTTGGTATCGGACCGGGGATCGGGTTCGCTGGCGCCATGATGGTGTTTTGGAGTTTCTGGGGCGAATAGACACGCAGGTGAAGCTGCGCGGGTATCGCATTGAGTTGGGCGAGATCGAAATGGTGCTAGGCGCTCACCCGAGCGTGAGCGGCTGTGCAATGGCGCTGAAGGAAAATGCAGCAGGTGACAAGCAGCTCGTGGGTTATGTCGTTGCGCGTTCCGGAGCCGCGGTGAGTACGGCGCAGGTACAGGCATGGCTGGGCGAACGCTTGCCAGGGTACATGGTGCCGTCTATTTGGGTGTGGCTGCAGACGCTGCCGCAATCGCCGAGCGGCAAAGTGGACCGTAAACACCTGCCGTTACCTGCCTTCGAGATAGGCTCCGTGAAAGCCAGTACCGCCGCTGAGGCAGCGCTGGTGAACATTTGGCAAAGCCTGCTGGGGTTGGCACAGGTTGGAGTACAGGACAATTTCTTTGCATTGGGAGGCGACTCGATTCTCGCCATCCAGATGGCTTCGCGTGCAGCCGAACAGGATGTGCGCATCACTGCCCAGGATGTGTTCCGTTACCCGACGATTGCCCAGCTGGCCGTCAATGGTGGTTTCGGTGCAGCACAAGGGGTGCTTGCCGAGCAAGGCCTTGTAGACGGTGAGGTAGCGCTCAGTCCGATCCAGAAATGGTATGTCGATTGGCCGGGAGCGGACTGGGAGCAGTTCAGCCAAGGGGTCTATTTTGATCTGCATGCACAAGTAGATCCGCAGTTATTGAGTGCGTCACTGGCGGCAGTCGCCAGGCATCATGATGTGTTGGGCATTGGCTGGCGCCATGACGGTAGCACCTGGCACCAGGAAAGCGGTGCAGGGGCTGCGGTGGAGGTGCTGGTTGAGGATTTGCGCGGGCAAGCGGACGCCTTGGCGTGCCTGGAGCAGAGTGCTGGAGCACTGCAGCAAAGTCTGAGCCTGAATGCTGCGAGCGTATGGGCGGCTCGAATTTACCGGCTGGATGAGGGATGGCGCCTGGTATGGCTGGTGCATCACGTGTCGGTGGATGGTGTTTCATGGCGAATCTTGCTGGAAGATCTGCTCAGAGCCTATGGCGCGCTACAGCGAGGGGAGGCGGTGAGCCTGCCGGCGAAGACGGTGTCTTACCAGGCTTGGACGCAACACTTGGCTACCTGGGGTAATCAGTTACCGGCATCGCAGTTGGCATACTGGCAGCGTATGGAAGGGTCAGGAACGGATGTGCCAATGGATGGCGATGCGTCGGTGAGCGAGGTGGGCAGCGAGGCCCGGGTTTCCTTGCAGTTGGACAGGCTTATGACGCAACAGCTGCTGCGTGAGGCGGGTGAACGGTATCGGGTACGTCCTGAAGAGCTGCTGGTGGCGGCTCTGGCGCGCACACTCTGTGCCTGGTCTGCCAGCCAAGAGTGCGTTGTGGATATCGAAGGTCACGGTCGCGATGGTGTGGAAGGCGTGGACGTGGGCCGCACCGTGGGTTGGTTTACAAGCCTCTATCCCCTGCGCCTGACGCTGGAGGGTGGGTTGGCGAATGACCTGAAAGCGGTGAAGGAGCGGATGCGTGGGGTGCCCCATGGCGGGCAGAGTTACGGTGCATTGCGTTATGGCCGTGAGGACAGTGGGTTAGGTCGGCATGAGCGTTCGGTGAGTTTCAACTACCTGGGCCAATGGCGATTGGACGAGCTAGGCACCCCCCTGGCGGGCTGGCGGGGTCAGGCACCCGGGGGATCGCGACGGCCAACCATGCGCAGGCGCCATGCGCTTGAAGTCCTGGCTTATGTCCAGGAGAGCCAGTTGCATGTTGACTTCCAGTACAGCGACCTGCTGCATCGAGCCGAAACGATGGCCACTCTGGCGCATTCTTTTCAGGTTGAATTGCAGGCGCTGCTGACGCACTGCTTATCGGTGGAACGTGGAGGGCTGACGCCCTCGGATCTGCCCTTGGCTCATCTTGATCAGAATGAAATCGATGAGATTGAGCATGATCATCCCCAGTTGGCAGACATGTACGGTGTTACGCCACTGCAACAGGGAATCCTCTTTCACTCTGTGGCACAGAACCCCAGTTTTCTGTATGTCGAGCAGCTACATTGGCGAATAGTCGGTGAGTTCAGAGCCGATTGTTTCCAACAGGCTTGGAGCGAGGTCATTCGTGCACATGCAGCGCTGCGTACAACGTTTCGTTGGCGAGACCTGAAGACACCAGTCCAGTTGGTCCATCATTTACTGGAACCTGATTGGGGCACTCTGGATTGGCGTGAACTGTCCGCTGAGACCTGTCGCACGCGTTTCGAAAACCTGTTGAACACGGACCGTGAGCGCGGCTTTGACTTGGAACACGGGCCATTGCTACGAGGCACCTTGATTCGTGAGCAAGAGAGTTCCTGGCGTTTCCTGTGGACCTACCATCATGTGGTGTTTGATGGGTGGTCGGTGGCGTTGATTCTCAAGCAGGTGCTCAATCGCTATGCCGGTTTGAATGCCGGCGCAGAGATTCTCCCGAGCAGTTTACGGCCATTTGTAAGCTGGCTGTCCGGGCGTGATCAGGAGGACATGTCTGTTTATTGGCAGGAGGTGTTGGGGGGCATTGTCGAACCCACGCTGACAGGTTTTGAGTCCCCAGCCCATAATCGACAGGCTCTTGCTCGGGATCGTTGTGCATTTCGCGTGGATGACGCGTTGTGTGATGCGCTGGGACTGGCCGCCAGACAGGCCGGGATCACCCAGGCCAGTGTGCTGACCGGTGCCTGGGCCTTGACCTTGGGCCTGGCCGGCGGTGGTTCGGATGTACTCTTTGGCACCACGTTATCCGGTCGGCCAGCTGACCTGCAGCAAGTAGAGCTCACAGTGGGGCTGTTCATCAATACAGTTCCCGTCCGCGTGCGCATTGATGACGACGACGTCGTTTCTGACTGGTTACAGCGTTTGCACCGTCAGCAAAGCGAGCGTGAGAAATACTCCACGGCATCACTGACGACGGTTCAACGCTGGGCAGGTCTGAACGGTGGGGATCTGCTGAGCAGTCTGTTCGTTGTAGAGAACTATCCGATTGACTCGATGCTAAAGCAATCCGATATCGGCGTGGACATTACCGAGCTGACTTCCATTGGCCATACCAACTTTCCTTTGACTGCCCAATGGGTTCCAGGCGAAGAAACGGTTCTGCATGTGATTTTTGATACCTCGCGTTATGACGAGGTCTCGATTCGCCGACTGGGTGACAGTTTTTTACGGGTACTCAGGCAACTTGTGCTGCAACCGCAGTCCAGGATCGGTGAGATTTCGTTGGTGAGCGAGGCTCAAACACAACAACTCATTTACGATTGGAACGATACCCCTGCGACCAGTGACGGTTTTTTGCTTCATGAGGGGATCAAGCGGTATGCGGCGCTGACGCCCAAGGCTGCGGCAGTTATCGGCGTAAGTGACCGGATGAGCTATGACGAGCTCGCGGCGCAGCAGGAACGTATCGCCACATCGGTGGTAGCAGCCAATGCACGATCCGAGCCGGTCGCGGTGTTTCTGCCACGCTCGTTGCACGCTGTTGCAGCCTATGCGGGCGTGATGCTGGCAGGTTGCGCATACGTTCCGGTCGACCCTGCGACGCCGCCGCGCCGCTTGCAGGAAATCTTCAGCACCATTGGCTTTGTGGTCACTACGCGAGCACTCGCTCCTCAGTTCGACGCCATCGCGGTGCAAACGATCCTGGTCGACGAGGTTGTATCAGCGCAACTGCCCGACGTCGCAATCAATAACTTGGCCTATGTCATGTTTACCTCCGGCTCCACAGGGAAACCCAAGGGGGTAATGATTGATCATCGCGCGGCTTCCCTGACGATCGAATCCATAATTGAGCGTTATGCCATCGGTACGAGGGATCGCCTTCTTTGCGTTTCTTCCGCAGGGTTCGATCTTTCGGTGTTCGACTTCTTTGGTGCATTCGCCGTGGGTGCAGCCGTAGTGCTGGCACCTGAGTCGACTACCGTTGACCCTGGCACCTGGCTAGATCTAATGGAACGAGAGCAAGTGACCGTCTGGGAGTCTGTGCCCGCGGTTATGGAGCTCTTATTGGCAGAATGTCGTCAGAGTGGGCGCAAACTGTCGTCCTCGTTAAGACTTGTGATGTTGAGCGGCGACCGGGTTGCCCTTGGGCTGCCTGAGCGTATTCGTGAGGCGGCAACCAGCGAGCTGGACATCATTGCTCTCGGTGGCGCGACGGAGGCAGCTATCTGGTCGTGTTATTACGACACAAAAGAACTGGCTCCGGGCGCGCACGTCATTCCTTACGGTCGCCATCTCCCGGGCCAGCGACTCTATGTGCTGTCCCCGGCCCTACGCCCTTTGCCCATTGGTGTTCCAGGCGATCTTTGGATTGCTGGTGCGGGGGTTGCACGCGGCTATCTCGGTCAGCCGGAGCTGACGTCCGAGCGATTTATGGCCGACCCGTATGTTCCCGGCCAAAGCATGTATAAGACCGGAGACCGTGCCCTTGTCCTGGCAGACGGCAACCACGAATTTCTCGGTCGGGTGGATGACCAGATCAAGATCGGCGGTTTGCGGATCGAGCTTGGTGAGATCGAGGCGGCCCTTATGCAGGCCCCTGGTGTCGAGCGTGGAGTTGTCTCCATCGTCGAGCACGACGGACGACGGATGATCGCAGCCTATGTTCTTCCTCACGCCGCCGAGGCTTTCGATACGGTGGCTGTTGGCGAATCACTGCGCCAGGCACTGCCAGCCTACATGTTACCTGCGTCAATCATGACGCTTGAATCTGTGCCCTTGACCGCAAACGGCAAAGTGGACCGTAAACGCCTGCCGTTACCTGCCTTCGAGATAGGCTCCGTGAAAGCCAGTACCGCCGCTGAGGCAGTGCTGGTGAACATTTGGCAAAGCCTGCTGGGTTTGGCACAGGTTGGAGTACAGGACAATTTCTTTGCATTGGGAGGCGACTCGATTCTCGCCATCCAGATGGCTTCGCGTGCAGCCGAACAGGATGTGCGCATCACTGCCCAGGATGTGTTCCGTTACCCGACGATTGCCCAGCTGGCCGTCAATGGTGGTTTCGGTGCAGCACAAGGGGTGCTTGCCGAGCAAGGCCTTGTAGACGGTGAGGTAGCGCTCAGTCCGATCCAGAAATGGTATGTCGATTGGCCGGGAGCGGACTGGGAGCAGTTCAGCCAAGGGGTCTATTTTGATCTGCATGCACAAGTAGATCCGCAGTTATTGAGTGCGTCACTGGCGGCAGTCGCCAGGCATCATGATGTGTTGGGCATTGGCTGGCGCCATGACGGTAGCACCTGGCACCAGGAAAGCGGTGCAGGGGCTGCGGTGGAGGTGCTGGTTGAGGATTTGCGCGGGCAAGCGGACGCCTTGGCGTGCCTGGAGCAGAGTGCTGGAGCACTGCAGCAAAGTCTGAGCCTGAATGCTGCGAGCGTATGGGCGGCTCGAATTTACCGGCTGGATGAGGGATGGCGCCTGGTATGGCTGGTGCATCACGTGTCGGTGGATGGTGTTTCATGGCGAATCTTGCTGGAAGATCTGCTCAGAGCCTATGGCGCGCTACAGCGAGGGGAGGCGGTGAGCCTGCCGGCGAAGACGGTGTCTTACCAGGCTTGGACGCAACACTTGGCTACCTGGGGTAATCAGTTACCGGCATCGCAGTTGGCATACTGGCAGCGTATGGAAGGGTCAGGAACGGATGTGCCAATGGATGGCGATGCGTCGGTGAGCGAGGTGGGCAGCGAGGCCCGGGTTTCCTTGCAGTTGGACAGGCTTATGACGCAACAGCTGCTGCGTGAGGCGGGTGAACGGTATCGGGTACGTCCTGAAGAGCTGCTGGTGGCGGCTCTGGCGCGCACACTCTGTGCCTGGTCTGCCAGCCAAGAGTGCGTTGTGGATATCGAAGGTCACGGTCGCGATGGTGTGGAAGGCGTGGACGTGGGCCGCACCGTGGGTTGGTTTACAAGCCTCTATCCCCTGCGCCTGACGCTGGAGGGTGGGTTGGCGAATGACCTGAAAGCGGTGAAGGAGCGGATGCGTGGGGTGCCCCATGGCGGGCAGAGTTACGGTGCATTGCGTTATGGCCGTGAGGACAGTGGGTTAGGTCGGCATGAGCGTTCGGTGAGTTTCAACTACCTGGGCCAATGGCGATTGGACGAGCTAGGCACCCCCCTGGCGGGCTGGCGGGGTCAGGCACCCGGGGGATCGCGACGGCCAACCATGCGCAGGCGCCATGCGCTTGAAGTCCTGGCTTATGTCCAGGAGAGCCAGTTGCATGTTGACTTCCAGTACAGCGACCTGCTGCATCGAGCCGAAACGATGGCCACTCTGGCGCATTCTTTTCAGGTTGAGTTGCAGGCGCTGCTGACGCACTGCTTATCGGTGAATGAGGGGGTCACTGCACTCGTCGCACAGCTGAATAATGTCGAGGCGGTTTATGGGCTGACGCCGATGCAGGAAGGCATGCTTTACCACGCGCTTGCCAGAGACGGAATGTACGTCGAACAGTTGGCCTGCACGCTGACAGGTATTTTGGATGAACAGGCTTTGCAGGACGCATGGAATGATGTGGTGGCGTCCAATCCAGTGTTGCGTACATCGTTTCATTGGGAGGGTTTGGCAAGGCCTGTGCAAGTAGTACACCAGGTTGCACAAGTACCTTGGGTGCTGGAGTCGTGGGCAGAAGGGCTGGACATGGACGCCTGGCTGCGGGCAGACCGGCGCAAGGGGCTGGACCTGCGGACTGCACCTTGCTTGCGATGCGCACTGCTACACACGGGGCCGCAACGCTACGAATGGGTTGTGACCTACAGCCACTTGCTGCTGGATGGGTGGTCGTTGTCGCTGATGATTGAGGCGCTCGCGCAGGCCTATGCGGCGCAAACAGCAGGGCAACCTTATCAGCCGCCAGTGCGTAGCCCATTCATTGATTACGTGAGCTGGTCACAGGCGACATTGGATCAGGGTGTGGGTGAGCATTTCTGGCACTCCCAGCTCTACGGTTTCGAGGGTGTCCGTTCACTATCGTTGCCGGTTCCGGACGTGACCGAAGCGTACGCAGAACCTGTATTGATCAATGTTCAGCGGTCTTTGGTCGCAACCCTGGAAAAACAACAACGAGTCACCCTGGCGACAGTCGTGGCGGGTTGCTGGGCAGTACTGTTGAGCCGTTATGGAGAAGGCGACGACGTCTTGTTTGGCATGACCAGTGCGGGGCGGCGGGCGCAGATAGAGGGCAGCGAGTCCATGATGGGGCTGCTGATCGAAACCCGGCCGACGCGCATTGAGGTAGACGAGCAGGCACCTTTGGGGGATTGGTTACGGACGATCATGCAGGAGGAGGCAAAGCGCGAAGAAGCGGGTGCAGTCTCTTTGGCTCAGATTGAGAGCTGGGGAGGGGCGGAACGTGGAGCACGATTGTTCGACACGCTGGTGGTGGTAGAAAACCAGCCGATGGCGATGATCGGTGACCTGCTAGGAAGTCAGGTGGTGGTGGCGAATGTGCGCACCGTGGAGTGCACGAACTGGCCCCTGACAGTGGTGGTATTGCCAGAACAAGAACAGCTACGGCTAGTGTTCCTGTACGACCCCGAACATTATGCCCGGCAGGCGATTGAGCAAGTCGCCAGGCATTTTTCGACGTTGTTGGCGTCTGCGGGTGAAGCCGTCCAGGTGGCCGACCTGCAGATGCTGGACGAGGCTGAGCGTGAAATGTTGGTTGAACGCTGGAGCGGTGCCGATCAGGTACACGCAGCTTCTAACCGGACCATCGTGGAGCGCATTGAGGAGCAGGCGACTCTACGTCCTGATGCTATTGCGTTGCGGTTAGGCGAGCGAAGCATGAGCTACGCCGAGTTGACGACGAGAGGGCGTCGTGTTGCCGCTTGGCTCCAGCGCCAGGACGTGGGTGTGGGTGGGCGTGTAGCCATTGTCGGCGAGCGGACAATGGAAACCATAGCCGCGATGTACGGGATCCTGTTGAGTGGTGCGGCCTACGTCCCGCTGGACCCGGATTGGCCAGAGGAGCGTAAGCGCCTGGTGATCGAGGATGCACAACCCCAGGTGTTCATTGGCTCGACACATATGGCATGTGGGTCGTCGCTACAGATATCGCTGGAGACCCTCGAAGGGTTTACCGATGAGCGATTGACAGGGCGGTCGGCTACGCCGCAAGACCTGGCGTATGTGATTTTCACATCGGGCTCGACCGGAAGACCCAAGGGGGTAATGGTTCGGCACGCAGACGTGATGCACCTGGACGGATTGCAGGACGCCATGGCGCTGAGTGACGCGGATGTATGGACCTCATTCCACTCGTATGCCTTTGACTTCTCTGTTCTGGAAATATGGTATCCGTTGATGTGGGGTGCAACGGTGGTCCCGGTGCCGTATTGGGTCAGCCGTGAGCCTGAGGCGTTCCTGGCGCTGATCTGCGCCGAGAAGGTCACGATCATTTGTCAGACACCCGCGGCTTTTGAACAGTTGATCTCCACGGCCCGGCCGGGTTGCCGGGCCGGTCATGTGCGCTGGGTGCTACTTGGCGGGGATCGGTACAGCGCGGCGTTGTTTGCAGCTGGCGATCCCGCCGAATTTCCGAACATCGCTAACGTATATGGCATCACCGAAACGACTGTGATAACCACTTTTGAGCCGCTGGAACGTGACCGACCGGTAGCTATCGGTCGGCCATTTCCAGGCCAGCGGATCTATCTGCTTGACCGGAAGAAGCGGTTGGTACCACCGGGGGCCGTGGGCGAGATGTACATTTGCGGCGAAGGTGTCGCCGCAGGGTATATGGGCGCAGAGGCGCTGACGGCCCAGCGCTTCAGCGATGACCCCTATCAACCCGGCGCGCGGATGTACCGTTCAGGTGATCTTGCACGGTTTTTGCCAGGCGGACGCCTCGAGTCGATTGGTCGGGCAGACCACCAAGTCAAGATCCGTGGCTACCGGATCGAACTGGGCGAAGTCGAGAGTGCACTGTCATCGCTTGCCGTCGTGAACGGGGCGATTGTCGACGTCCGCAATGGGCCCAATGGCCGTCAACTTGTCGCTTGGTATGTGGCTGCCGAAAGTGTCAGTGCGCTGGATGTTCGTGCTGCCTTGAAGTCTCTGCTGCCTGAAAGCGCTATACCGTCGGCACTGATTCGTGTCGATGCATTTCCATTGACACCCAATGGCAAGGTAGACCGAAAGGCTCTTCCTCTCGAGGACGCCGTGTCATTACCGTCAATAAGGCCGAGCAGTCATAACGAAATGGCTATCGAGGCCATCTGGTGCGAAGTGCTGGGCCAAGAGGCAATTGGGGTTCATACGAACTTCTTCGACGCCGGTGGCGACTCAATCGCAATCGTGCGGGTGCACGGATTAATGGCCGTGTTACCGGGTGCTGAACGGCTGCGTGTCGTGGATCTCTTCCAGTGTCCCACCATTGCTGCGATCGCCGAAAAAATCACGTCCAGCGAAGCACAGACGGCAGTAGGCGATGACTCGTCTGCACGCGGCGTGCGCCGCCGCCAGGCCCTCGAGCGCCACCAAAACGCAAGGAGCAAGCCACAATGA	MTIAQLLADLADVGVTLRRCGEQLEVEGPTGSLGPDLLERLRQSKQALLQMIQDENALLTKMPLPVPGEGTEACELSLGQQRLVVATQLGEPTIYNEQAAIEFAADVDVLAITEAFAALAHKHDILHTVFTDDEPSQQTVIADARVPLQSWEVRSNDELHTLARSIAQIPFVNGKLLWRVDLFYKATGSVVLVLTIHHAIFDRWTMMLLIRDFSQFLQHPSHVNVAQAASLTYRDFSVWQRRWMDTPEYAAQLDWWKDLLSGIDSFPVIQGDRPPPAVPSGRGATERMKIPADCIRAASEFSRQQNTTLFSTLLSIFQLLHHRYTGESQVLTLAPVASRPFQEAEEIAGFFVNLVAIVGRVYKDDTFHSLVERTRGITTQAFSHQFVPFDAVVEHLRQTRGPRSDQLAHVVFALQNVNLPTVRVEGVDAKPFDLDSPFARFDLYLSIEGDERGMFAVWQYSQDLFDASTIRKMGEHYVSLLRGVLAAPEAPLQSLPMYSDVEYAQLQAWSRHEQPYRADATVVALFREQAAAHPEQTALEQGTECWTYAQLERWSDRAAAVLRSAGAGRGSIIGVTGERSPRLIAAFLACLKAGGAYLPLERNYPDARLSEMVADAEPALILVADDLEPGWLSSYPGPVLKLSACEAELPFPSTLESGAGDLAYVMYTSGSTGKPKGVCIEHRGIVRLATGAGFMQLDTSTVMLQASSLGFDTSTFEIWGCLLNGGRLVLVEQGPLILEAMADTIVSKGVTCAWLTADLFRLMVEEQVASLRGLRELLAGGDALPVASCKAFLEACPDVALINGYGPTENTTFTSTHRVTQEDVHRVSIPIGRPLGNTQVWVVNENGCPVPPGVPGELWTSGDGLARGYLGREDLTVERFVQGPLLGGGRWYRTGDRVRWRHDGVLEFLGRIDTQVKLRGYRIELGEIEMVLGAHPSVSGCAMALKENAAGDKQLVGYVVARSGAAVSTAQVQAWLGERLPGYMVPSIWVWLQTLPQSPSGKVDRKHLPLPAFEIGSVKASTAAEAALVNIWQSLLGLAQVGVQDNFFALGGDSILAIQMASRAAEQDVRITAQDVFRYPTIAQLAVNGGFGAAQGVLAEQGLVDGEVALSPIQKWYVDWPGADWEQFSQGVYFDLHAQVDPQLLSASLAAVARHHDVLGIGWRHDGSTWHQESGAGAAVEVLVEDLRGQADALACLEQSAGALQQSLSLNAASVWAARIYRLDEGWRLVWLVHHVSVDGVSWRILLEDLLRAYGALQRGEAVSLPAKTVSYQAWTQHLATWGNQLPASQLAYWQRMEGSGTDVPMDGDASVSEVGSEARVSLQLDRLMTQQLLREAGERYRVRPEELLVAALARTLCAWSASQECVVDIEGHGRDGVEGVDVGRTVGWFTSLYPLRLTLEGGLANDLKAVKERMRGVPHGGQSYGALRYGREDSGLGRHERSVSFNYLGQWRLDELGTPLAGWRGQAPGGSRRPTMRRRHALEVLAYVQESQLHVDFQYSDLLHRAETMATLAHSFQVELQALLTHCLSVERGGLTPSDLPLAHLDQNEIDEIEHDHPQLADMYGVTPLQQGILFHSVAQNPSFLYVEQLHWRIVGEFRADCFQQAWSEVIRAHAALRTTFRWRDLKTPVQLVHHLLEPDWGTLDWRELSAETCRTRFENLLNTDRERGFDLEHGPLLRGTLIREQESSWRFLWTYHHVVFDGWSVALILKQVLNRYAGLNAGAEILPSSLRPFVSWLSGRDQEDMSVYWQEVLGGIVEPTLTGFESPAHNRQALARDRCAFRVDDALCDALGLAARQAGITQASVLTGAWALTLGLAGGGSDVLFGTTLSGRPADLQQVELTVGLFINTVPVRVRIDDDDVVSDWLQRLHRQQSEREKYSTASLTTVQRWAGLNGGDLLSSLFVVENYPIDSMLKQSDIGVDITELTSIGHTNFPLTAQWVPGEETVLHVIFDTSRYDEVSIRRLGDSFLRVLRQLVLQPQSRIGEISLVSEAQTQQLIYDWNDTPATSDGFLLHEGIKRYAALTPKAAAVIGVSDRMSYDELAAQQERIATSVVAANARSEPVAVFLPRSLHAVAAYAGVMLAGCAYVPVDPATPPRRLQEIFSTIGFVVTTRALAPQFDAIAVQTILVDEVVSAQLPDVAINNLAYVMFTSGSTGKPKGVMIDHRAASLTIESIIERYAIGTRDRLLCVSSAGFDLSVFDFFGAFAVGAAVVLAPESTTVDPGTWLDLMEREQVTVWESVPAVMELLLAECRQSGRKLSSSLRLVMLSGDRVALGLPERIREAATSELDIIALGGATEAAIWSCYYDTKELAPGAHVIPYGRHLPGQRLYVLSPALRPLPIGVPGDLWIAGAGVARGYLGQPELTSERFMADPYVPGQSMYKTGDRALVLADGNHEFLGRVDDQIKIGGLRIELGEIEAALMQAPGVERGVVSIVEHDGRRMIAAYVLPHAAEAFDTVAVGESLRQALPAYMLPASIMTLESVPLTANGKVDRKRLPLPAFEIGSVKASTAAEAVLVNIWQSLLGLAQVGVQDNFFALGGDSILAIQMASRAAEQDVRITAQDVFRYPTIAQLAVNGGFGAAQGVLAEQGLVDGEVALSPIQKWYVDWPGADWEQFSQGVYFDLHAQVDPQLLSASLAAVARHHDVLGIGWRHDGSTWHQESGAGAAVEVLVEDLRGQADALACLEQSAGALQQSLSLNAASVWAARIYRLDEGWRLVWLVHHVSVDGVSWRILLEDLLRAYGALQRGEAVSLPAKTVSYQAWTQHLATWGNQLPASQLAYWQRMEGSGTDVPMDGDASVSEVGSEARVSLQLDRLMTQQLLREAGERYRVRPEELLVAALARTLCAWSASQECVVDIEGHGRDGVEGVDVGRTVGWFTSLYPLRLTLEGGLANDLKAVKERMRGVPHGGQSYGALRYGREDSGLGRHERSVSFNYLGQWRLDELGTPLAGWRGQAPGGSRRPTMRRRHALEVLAYVQESQLHVDFQYSDLLHRAETMATLAHSFQVELQALLTHCLSVNEGVTALVAQLNNVEAVYGLTPMQEGMLYHALARDGMYVEQLACTLTGILDEQALQDAWNDVVASNPVLRTSFHWEGLARPVQVVHQVAQVPWVLESWAEGLDMDAWLRADRRKGLDLRTAPCLRCALLHTGPQRYEWVVTYSHLLLDGWSLSLMIEALAQAYAAQTAGQPYQPPVRSPFIDYVSWSQATLDQGVGEHFWHSQLYGFEGVRSLSLPVPDVTEAYAEPVLINVQRSLVATLEKQQRVTLATVVAGCWAVLLSRYGEGDDVLFGMTSAGRRAQIEGSESMMGLLIETRPTRIEVDEQAPLGDWLRTIMQEEAKREEAGAVSLAQIESWGGAERGARLFDTLVVVENQPMAMIGDLLGSQVVVANVRTVECTNWPLTVVVLPEQEQLRLVFLYDPEHYARQAIEQVARHFSTLLASAGEAVQVADLQMLDEAEREMLVERWSGADQVHAASNRTIVERIEEQATLRPDAIALRLGERSMSYAELTTRGRRVAAWLQRQDVGVGGRVAIVGERTMETIAAMYGILLSGAAYVPLDPDWPEERKRLVIEDAQPQVFIGSTHMACGSSLQISLETLEGFTDERLTGRSATPQDLAYVIFTSGSTGRPKGVMVRHADVMHLDGLQDAMALSDADVWTSFHSYAFDFSVLEIWYPLMWGATVVPVPYWVSREPEAFLALICAEKVTIICQTPAAFEQLISTARPGCRAGHVRWVLLGGDRYSAALFAAGDPAEFPNIANVYGITETTVITTFEPLERDRPVAIGRPFPGQRIYLLDRKKRLVPPGAVGEMYICGEGVAAGYMGAEALTAQRFSDDPYQPGARMYRSGDLARFLPGGRLESIGRADHQVKIRGYRIELGEVESALSSLAVVNGAIVDVRNGPNGRQLVAWYVAAESVSALDVRAALKSLLPESAIPSALIRVDAFPLTPNGKVDRKALPLEDAVSLPSIRPSSHNEMAIEAIWCEVLGQEAIGVHTNFFDAGGDSIAIVRVHGLMAVLPGAERLRVVDLFQCPTIAAIAEKITSSEAQTAVGDDSSARGVRRRQALERHQNARSKPQ	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	733.99	gnl|BL_ORD_ID|4935|hsp_num:0	5928			237	1629	colistin A; colistin B
BGC0001045.1|Spiruchostatin_14 # 32106 # 36674 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.579	BGC0001045.1|Spiruchostatin_14 	32106	36674	+	Loose	750	28.8758	adeF	27.43	3000777	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATACGTCGAACGCTATCGCGATCATCGGTATGGGCTGCCGGTTCCCCGGAGCGTCATCCCTGGAGCAGTTCTGGACGAATCTGGTAAACGGTGTTGAGTCGATCACCTCCTTCGGCCCAACCAGGCACCATGAAGCCTGGCAGGAGGTTTCTTCTGCGGGCATTGTGGACAACGCCTCATTGTTTGACGCTGCATTGTTCGGTCTCAGTGCGCGCGAGGCTGAGCGGATGGACCCCCAACATCGGGTCTTCCTTGAGTGTGCCTGGGAAGCGCTGGAGCGCTCAGGCTATTACCCAAAACAGCTGCCAGGGCGGGTAGGGGTTTTTGCAGGCACGGGCTTCAATGAGTACTTGGTACGCAACATCATGCCCTTGGCGCCGGAGGGTGATCTGTCGTTGTTATTGACGAATGACGCCTGTTTCCTGTCTTCACGCCTGGCCTATCTTCTGGGATGCTCAGGCCCGGCAATTGCAGTCTCAAGTGCATGCTCGACGTCACTCGTTGCCGTCCATCTTGCCGTCCAGTCACTGCTGATGGGTGAATGTGATACAGCAATCTGCGGTGGTGTGCGTATCACCACACCACAGAACCGACCCTACCGTCACGAACCGGGCGGTATCGGCTCATCGGACGGTCATTGCAGGGCCTTCGACAGTGCCGCCAACGGTACTGTCAGTGGCAATGGGGCGGGTGTGGTGGTGTTGCGCCGTCTCGACGATGCGCGCAACGACGGTGATCCTATTGCGGCTGTTATTCTCGGGAGCGCCGTTACCAACGATGGGGCACAACGTGTCGGTTTCACCGCGCCTGGCGTTAATGGACAGTGCGCTGCCATTTGCGAAGCACAGGCCTTGGCTGATGTTTCTCCTGACTCGATCGGTATGCTCGAGGCTCACGGTACTGCAACGACCCTGGGCGACCCGGTGGAGTTTGAAGCGCTGAGCGCGGCTTTCCGACATGGCACTACACGCCGCGGTTTCTGCGCCTTGGGGTCGGTCAAAACCAACATTGGTCATCTTGATGCAGCGGCGGGCATCGCTGGACTGATCAAAACGGTGCTTGCCTTGCAGCATCGGGTTATTCCTGCGTCGCTTCACTTTCGCGAGCCCGGTTCCGGCATCAACTTGCAGGAATCACCGTTTTTCGTCACCGCCACTGCGCGCCCTTGGCTCGAGGCAACACGGCGTGCTGGCGTCAGTTCGTTCGGCATGGGGGGGACAAACGCGCACATCGTTCTGGAATCCGCGCCTGAACCATTGGGCGATACTTGCGAGACGGCTGAACCGCAGTTGCTTGAACTGTCGGCTCGGTCAGAGGCCTCGCTGCATCAGATGGCACAGCAGCTTGCTGATCATCTTGAGCGTGAACAGCCACTGCTGGCCGATGTGGCCTATACGCTTGCTGTCTCACGTAATGCCTATGAGTGGAAAACCTCAGTAGAGTGCACATCGCTTGCAGAAGCGGCGGAGGCACTCAGGGGTCCGCTTCAGATCACACGGTCATCCTGTGCAGCACAGATCCCGCGAGCATCCAGACGCCGGATCCACCTGCCTGCAACGCCCTTCGAGCACAAACATTACTGGGTCGACCCACCTTCGTCCTTTGCATACAGGGCGAATCCGGCTGACTGGCTCTACACTCCGCGTCTTCGACAGAGTATGCCGTTGGAGCAACTACTTATCGACAGCCAGCGTAATTGGCTGGTGCTCCTGGATGATCATGGGGTCGGGCAACGTATTGCTGCCGCTCTGCGTGACGCGGGGGCACAGACAGTCGTTGAGCTGGTGTATACCGACGATACCGTATCGGATGTGATCCATACGCAGGTCGAGGCTGATTGGAGTCGTCCTCTCTCGGTTATTTCCTTATGGAGTCTGGCAGCCCAAGACAGCAGCGATGACCGTGAGGTGCTGCAACGGCACTACCTCAGGCCAGCACAGGTGTTGCGAGCTTGGGCAGACAAAGCTGGCGGCGATGTTGACGTGACCTTTGTTGTCAATGGCGCTTTCGATGGATTCGGGTCACCCACTGCGCCAGAAAAAGCGATGTTGCTGGGGCTGGCGCGCGCATTGCGGCTCGAATATCCCAGTTGGCTAGCGAGGGTCATGGATGTTGAGATGCTCGCGCAGGACACCGTCGAATGTATCCTCGCTGAGGCCACTGCGTGCTCCGCTGACGATGCGGTCATTCATAAATACCGGTCACGCTGGGTTGAAACCGTTGAGCCCGTCACGATTTCGGGAGGGCATACACTCCCTATTCGACGTGGGGGTGTTTATCTGGTTACAGGCGGTAACAGCGGAATCGGGTTGGCAATCAGCAGATACCTGATCGACAGCTGGGGTGCGCATGTTATCGCGCTGAGTCGTCGTGGTGGTCAGTCTGGCCAAGGATTCACTGCCGTTGCGGCCAACCTCGACAATATCGACGAGTTACGGCAAGTGGTGGTCAGTATTCAAGCCGAGCATGGCCCCATCAATGGCCTTGTGCATTGCGCTGGCATGCCACCGCACGCCTTGCTGCGAACCGCGACGGATGCAGCAGTCAAGGAGGTTTTTGCAGGGAAGTTTTTTGGAGCGCTCAATTTACAGCGCGTGATGCTCCAGATGCCTCTGGATTTTGTGGTGCTCAGTTCCTCGTTACGCGCCCATATTCCTGCAGCAGGATCGGGAGATTACATGGCGGCGAATCTGGCGCTGGAAGCACTGGCGACGTCATGGGCTGCAACCGGAGCACGCGTGCTCTCCATCGCCTGGGACACCTGGAGCAAAGTGGGAATGGCCGCAACGGCTTCCGATGCGCGCTTCGTTACGGATGAACTTGACGCTGAGGGGATGAGCGTTGAAGAGGGGGTTAAGCTCTTCGAGGCGGCATCCCAATGCGGTTTGTCGCGCGTAGTCGTTAGCACACGGCCGTTTTCGGCCCTGAAAGCCCATGCCCAAGAGGCATTTTCAGTGGGGCGGGCGGGCGAGGTTGCGCAACGGGTAAGTTCCACCCGGCATCCACGACCTGCACTTAATACAGTTTATATACCGGCCCGCACCGCACTCGAAAGCCAGTTGGCGCAAATTTGGTCCGAAATCCTTGGTTATGACACCATCGGAATCAAGGATGATTTTTTCGATTTGGGCGGCGACTCTGTTGCGACGCTGCAAATTGTTGCTCGCGCCCGAGAGCAGGGGTTGAACCTGGAAACCAGCCGGGCATTTGAGGCGCACACTATTGAAGAGTTTGCCGCTGCCACTCGTATTGAGCTGGCTGAGGAGCTCCTTCTCGGCGACACGCCGTTGCCACTTTCTGCGGCACAGCAATGGTTGTTTGCTTGCGAGTCGGGGGATATTAACCGATTCGTCCAAGGGGTCGTCATCAACCTGCCCGAGGGTACCGACGTGCTATCGGTGGGTGCCGCAATTGATGCTGCCGTGGCGCATCGTCGGGTGCTTTCGGTTCGGTTTGCGCAAACCGAGTCGGGTTGGAAGCAGCTTCTGGGCGCGTCGCAATCCGTAGCTGTCGAGGTTCATCAATACGTTGGGTCGCCCGCAGGACAACTGGATCATGCGATTGAAATGGGTGGGACTCTGCAGCGCTCAATGGACATCCAGGCGCCGCTACTGGTACGTGCCGCGATTGTGTCCAGCCCTGTCGAATCGCACTTGGTGATCGTCGTCCACCATCTACTGATCGATGCCTCTGGTTGGCGAATACTCCTGGATGATATTTGCGCACGCGTTGCAGACCTTGGCCGAGCTACCGACGTACCGGATGAAGCCTTTCTGCAATGGGTTATCCATCTTGATGGTATCGCACAGGACGCGAAGATCAACGAGGAGGAGGCAGCCTATTGGGCATCCCTCGATCTTCCGGACCAGGATTTTCCTGCATTGCGACGTAAGGGATCGACAGGTTCCTTGACCTCGACGCTTTCAGTGGCGCAAACACGGGTTTTGACCTCAAGTCGCAAATCTATCGAAGCGCTGCTTGCTACGGCTGTCGCCTATGCTTTACGTCCCGTTGCTATGTCAGACCGAATCTTGATTGACATTGAGTCATTGGGGCGCGGTTGGTCCCGCGTCCCACAGGATGTCTCCCGGGCAATGGGTTGGTTCACCGCTATCCATCCACTGGTCATAGATACGGCTCAGGGCATTTACGCTGCGGCAGCGCAAGCCGCAACACTTGTACCACAAGCGCGCCACCGTGCTGTGGCGTACACCATGTTGCGCCAGCATGCGCCGGACCTACTGCCGCCCGTGTTGCGAAGTGATGCTCCGGTTTCGGTTGTCTTCTTCCCGGCCCCCACTACCGTGCCTGGCTGGTCGATCGCCTCTATCCTACCTCCACCAGAGGGGATGCCGGCGCCACACGCAGTTGCACTCGCAGCAACCATTGAAAATGGAGCACTCACTTTGCAATGGCACGGGCAGACAGATCCGTTCGAAGGTATGGCGCTTGCCACCCTTGTGTCGCGAACAATGCAGGGACTTCGGGAACTGGTGGCGGGTGGAAAGGACCAGATGAGTGCGCTTATGACTCAGCTTGACATGTCAGGGGTGGATGATGAATGA	MNTSNAIAIIGMGCRFPGASSLEQFWTNLVNGVESITSFGPTRHHEAWQEVSSAGIVDNASLFDAALFGLSAREAERMDPQHRVFLECAWEALERSGYYPKQLPGRVGVFAGTGFNEYLVRNIMPLAPEGDLSLLLTNDACFLSSRLAYLLGCSGPAIAVSSACSTSLVAVHLAVQSLLMGECDTAICGGVRITTPQNRPYRHEPGGIGSSDGHCRAFDSAANGTVSGNGAGVVVLRRLDDARNDGDPIAAVILGSAVTNDGAQRVGFTAPGVNGQCAAICEAQALADVSPDSIGMLEAHGTATTLGDPVEFEALSAAFRHGTTRRGFCALGSVKTNIGHLDAAAGIAGLIKTVLALQHRVIPASLHFREPGSGINLQESPFFVTATARPWLEATRRAGVSSFGMGGTNAHIVLESAPEPLGDTCETAEPQLLELSARSEASLHQMAQQLADHLEREQPLLADVAYTLAVSRNAYEWKTSVECTSLAEAAEALRGPLQITRSSCAAQIPRASRRRIHLPATPFEHKHYWVDPPSSFAYRANPADWLYTPRLRQSMPLEQLLIDSQRNWLVLLDDHGVGQRIAAALRDAGAQTVVELVYTDDTVSDVIHTQVEADWSRPLSVISLWSLAAQDSSDDREVLQRHYLRPAQVLRAWADKAGGDVDVTFVVNGAFDGFGSPTAPEKAMLLGLARALRLEYPSWLARVMDVEMLAQDTVECILAEATACSADDAVIHKYRSRWVETVEPVTISGGHTLPIRRGGVYLVTGGNSGIGLAISRYLIDSWGAHVIALSRRGGQSGQGFTAVAANLDNIDELRQVVVSIQAEHGPINGLVHCAGMPPHALLRTATDAAVKEVFAGKFFGALNLQRVMLQMPLDFVVLSSSLRAHIPAAGSGDYMAANLALEALATSWAATGARVLSIAWDTWSKVGMAATASDARFVTDELDAEGMSVEEGVKLFEAASQCGLSRVVVSTRPFSALKAHAQEAFSVGRAGEVAQRVSSTRHPRPALNTVYIPARTALESQLAQIWSEILGYDTIGIKDDFFDLGGDSVATLQIVARAREQGLNLETSRAFEAHTIEEFAAATRIELAEELLLGDTPLPLSAAQQWLFACESGDINRFVQGVVINLPEGTDVLSVGAAIDAAVAHRRVLSVRFAQTESGWKQLLGASQSVAVEVHQYVGSPAGQLDHAIEMGGTLQRSMDIQAPLLVRAAIVSSPVESHLVIVVHHLLIDASGWRILLDDICARVADLGRATDVPDEAFLQWVIHLDGIAQDAKINEEEAAYWASLDLPDQDFPALRRKGSTGSLTSTLSVAQTRVLTSSRKSIEALLATAVAYALRPVAMSDRILIDIESLGRGWSRVPQDVSRAMGWFTAIHPLVIDTAQGIYAAAAQAATLVPQARHRAVAYTMLRQHAPDLLPPVLRSDAPVSVVFFPAPTTVPGWSIASILPPPEGMPAPHAVALAATIENGALTLQWHGQTDPFEGMALATLVSRTMQGLRELVAGGKDQMSALMTQLDMSGVDDE	MNISKFFIDRPIFAGVLSVLILLAGLLSVFQLPISEYPEVVPPSVVVRAQYPGANPKVIAETVASPLEESINGVEDMLYMQSQANSDGNLTITVNFKLGIDPDKAQQLVQNRVSQAMPRLPEDVQRLGVTTLKSSPTLTMVVHLTSPDNRYDMTYLRNYAVLNVKDRLARLQGVGEVGLFGSGDYAMRVWLDPQKVAQRNLTATEIVNAIREQNIQVAAGTIGASPSNSPLQLSVNAQGRLTTEQEFADIILKTAPDGAVTRLGDVARVELAASQYGLRSLLDNKQAVAIPIFQAPGANALQVSDQVRSTMKELSKDFPSSIKYDIVYDPTQFVRASIKAVVHTLLEAITLVVVVVILFLQTWRASIIPLLAVPVSIIGTFALMLAFGYSINALSLFGMVLAIGIVVDDAIVVVENVERNIEAGLNPREATYRAMREVSGPIIAIALTLVAVFVPLAFMTGLTGQFYKQFAMTIAISTVISAFNSLTLSPALAALLLKGHDAKPDALTRIMNRVFGRFFALFNRVFSRASDRYSQGVSRVISHKASAMGVYAALLGLTVGISYIVPGGFVPAQDKQYLISFAQLPNGASLDRTEAVIRKMSDTALKQPGVESAVAFPGLSINGFTNSSSAGIVFVTLKPFDERKAKDLSANAIAGALNQKYSAIQDAYIAVFPPPPVMGLGTMGGFKLQLEDRGALGYSALNDAAQNFMKAAQSAPELGPMFSSYQINVPQLNVDLDRVKAKQQGVAVTDVFNTMQIYLGSQYVNDFNRFGRVYQVRAQADAPFRANPEDILQLKTRNSAGQMVPLSSLVNVTQTYGPEMVVRYNGYTSADINGGPAPGYSSSQAEAAVERIAAQTLPRGIKFEWTDLTYQKILAGNAGLWVFPISVLLVFLVLAAQYESLTLPLAVILIVPMGILAALTGVWLTAGDNNIFTQIGLMVLVGLACKNAILIVEFARELEMQGATAFKAAVEASRLRLRPILMTSIAFIMGVVPLVTSTGAGSEMRHAMGVAVFFGMIGVTFFGLFLTPAFYVLIRTLNSKHKLHSAAVHEAPLASPHDH	143.72	gnl|BL_ORD_ID|132|hsp_num:0	153			711	1038	tetracycline
BGC0001045.1|Spiruchostatin_15 # 36664 # 37839 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.605	BGC0001045.1|Spiruchostatin_15 	36664	37839	+	Loose	300	26.5646	AAC(3)-IXa	32.73	3002543	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGATGAATGACCGAGTTGCGGCATTTTCGGCGGTTGAAGCGGCACTGGCTGCACCGGAGGCAGCATTGGCGGGCGGTGACTTTGCTACGGTCGAGCAGTTAATGAGTGACATCCGTGGGGCAAACCGGGCGAGGGGGCTTTGGCTTCCTCAGCTGTCACGAGTCAATGGTGGTTCAGGGCTCGACCTGCTCGAACTGGTCGAGGTTGGAGAAGTCCTTGGCAGGTCGCCACTGGGCCATTATGCGGTTAACTATCAGGCACCTGATGCCGGTAATATCGACATCCTTCTTGAGTACGCAACGTCTGAGCAGAAAAGGCGTTGGCTTGATCCTTTACTGCAGGGCAAGGTTCGCAGCTGTTTTGCGGCAACCGAGCCGGACAGGGCCGGTTCCAATCCCTCTGCTCTGGCGACCAAGGCTGTGTTCAAGGAGGGAGCATGGCATCTCACGGGCCGTAAGTGGTTCGCCTCGGGTGCGGACCGTGCGGCATTTGCGATCGTGCTCGCCGTTACCGATGAGACCGCGCCACTGCACGCGCGAACCAGTACTTTTATCGTACCGACTGACGCACCCGGGTATCGGCATGTTCGTAACATTCGCGTGATGGGCGACGAGGGATGCGGCTGGGCGAGCCATGGTGAAATCGAGCTGGACGACTGTCGGGTTGAGACAGACGCGTTGTTGGGAGAGCCAGGGGCTGGGTTCGTCGTCCTGCAGTCCCGCCTTGCCACGGGACGGCTACATCATTGCGCGCGCTGGATTGGTGTTTGCGAGCGTGCGTTCGCCATTATGTGTCGACGGGCCAGCCGTCGCGAGCTTGCACCGGGGGAGTTTTTGTCGTCGCGCCAGACGGTACAGAACTGGATTGCTGAAAGCCGTGCGTCGATCGACGCGGCCCGGCTCCTTGTCGCTCAGGCCGCGTCGCGCTTGCAGAAGCGCCATGAGCGAGCCCAGGTTGACATATCAATAGCGAAATTTTTTGTCGCCGGAGTCACTCAGACCGTCCTTGATCACGCCCTGCAGATCCAGGGTGCACTCGGTGTCAGCGGTGACACGATCGTAAACGTCTTCTGGCGCCATGAGCGCGCAGGACGCATTTATGACGGCCCCGATGAAGTACACAAGGCGCTGGTCGCGCGGCACGCGCTGGCCGCGTTTCGTGGTGAGCCTCGATGA	MMNDRVAAFSAVEAALAAPEAALAGGDFATVEQLMSDIRGANRARGLWLPQLSRVNGGSGLDLLELVEVGEVLGRSPLGHYAVNYQAPDAGNIDILLEYATSEQKRRWLDPLLQGKVRSCFAATEPDRAGSNPSALATKAVFKEGAWHLTGRKWFASGADRAAFAIVLAVTDETAPLHARTSTFIVPTDAPGYRHVRNIRVMGDEGCGWASHGEIELDDCRVETDALLGEPGAGFVVLQSRLATGRLHHCARWIGVCERAFAIMCRRASRRELAPGEFLSSRQTVQNWIAESRASIDAARLLVAQAASRLQKRHERAQVDISIAKFFVAGVTQTVLDHALQIQGALGVSGDTIVNVFWRHERAGRIYDGPDEVHKALVARHALAAFRGEPR	MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDVVGARGTLMVPCGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPDASFAALGPAAAELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYEQPILVNGQRVWRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNFAINWIEAKLKR	139.15	gnl|BL_ORD_ID|1870|hsp_num:0	2030			132	288	neomycin
BGC0001045.1|Spiruchostatin_16 # 37836 # 38804 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.574	BGC0001045.1|Spiruchostatin_16 	37836	38804	+	Loose	500	45.0542	mphA	30.56	3000316	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAGCCTGCAGGTTGCACACAGCACGATGACGGCTCTGGGGAGTCCCGGTGCAGCCGCACTGGCGACCCGTATCGGAGCAGGTCGATCCAGTGAGACATACCTGGTGCAGGCGAACGATCGCGACCTCATCACTTATGTTTTGCCATCTGGCAGTGCGCGGGAAGCGCAACGTCGTTTCGCAGTCTTGGCGCAGATTGCTGAGCGCTATCGTCTAGCACCCAAGCCGCTTGCTGTGGTAGAGGCCTGCGACGAGGGTCGGACATTACTGGTGATGGAGCGGCTCCCAGGGGTTTTGCCGACGGCCTGTGGCTCTCTTTCACCTGATATGGTTCGTCGTCTCTGCGCCGGCTTTATTTCTGCGCTGGCGTCATTGCATGCTATTGAGATTGCTCCTGTTGATCGGCCTCCGGATTATCTGCGTCGAAGTATTGGTGATTGGGAGCGGCGATGGTGCGAAGAAGAGGCGGCAGGTGCTCACGATGACTTCAAATCCGTGGTGCGGTGGTTGGCGGATAATCTGCCGGACCAGGTTGCGTCAGCTTTTGTGCACAATGATTTTAAGCTGGACAACATTCTGGTCGATCCCGGCGACCCCGCACGGGTGGTTGGGGTCGTGGACTGGGAGTTGGCCACCATTGGCCATCCCCTTGCCGATTTAGGAGTCGCTCTGGCTTATTGGATTGAACGTCGTGACTCTTCGTTGTTGCGTCTTGAAGCGCCAGGGCCAAGCTGCGCTTTAGGGGCGCCGACCCGTCAGGAACTGGTTGAACTGTACTCTGCGGCCAGCGGTCGCGAAGTGCTGCATGCCTCGTATTGGTATGTCTACGGATTACTGCGTCTGGCGGTTATCACCCAGCAATTGGTATTGCGTCATAAAGACGGTGGCCAATCCGTTCCACGTGGTTTGCTAATCGTACGATCGCTCTTGGCGCATGCATCGAACACTTGTGGGAGCGGACGACTATGA	MSLQVAHSTMTALGSPGAAALATRIGAGRSSETYLVQANDRDLITYVLPSGSAREAQRRFAVLAQIAERYRLAPKPLAVVEACDEGRTLLVMERLPGVLPTACGSLSPDMVRRLCAGFISALASLHAIEIAPVDRPPDYLRRSIGDWERRWCEEEAAGAHDDFKSVVRWLADNLPDQVASAFVHNDFKLDNILVDPGDPARVVGVVDWELATIGHPLADLGVALAYWIERRDSSLLRLEAPGPSCALGAPTRQELVELYSAASGREVLHASYWYVYGLLRLAVITQQLVLRHKDGGQSVPRGLLIVRSLLAHASNTCGSGRL	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	106.98	gnl|BL_ORD_ID|1139|hsp_num:0	1243			321	744	erythromycin; roxithromycin; telithromycin; clarithromycin; azithromycin; dirithromycin; oleandomycin
BGC0001045.1|Spiruchostatin_17 # 38801 # 41020 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.564	BGC0001045.1|Spiruchostatin_17 	38801	41020	+	Loose	1900	28.1054	MuxC	28.79	3004075	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAGCAAACATTCAGGACATCCACGGCCTCGCACCCTCGCAGCACGGAATGCTGCTTGAAAGCACTAATGGCTTGACCCAGGGCGATATGTTCATAGAGCAAAGCGTTCTGTTGGTTCGCGGGAAACTTGATACCCCGCGTTTTCTTTCGGCTGTCGAGCAGATCGCAACCATCCATAGCAGTTTGCGCAGTTGTTTTGCATGGGAGGGCGAGACCCCTTTGCACGTTGTGTTCGATAAGGTTCGGCCTGTCGTGGAGTGGGAAGATTGGCAGAGTAAAGAAGGTGCAGATGATCGGCAAACGCTGGAAGCGTGGCTGGCGGCAGACCGTTCACGAGGTCTTGCCGTTAATCGTGCACCCCTGTGGCGGTTCACGGTCATTCGTTGCGCCGAGGAGGTGCACCGGGTCATTTGGACCCATCACCACCTGATTACAGATGGATGGTCAATTGCAGTGGTTCTCAACGATTTGCTCGACCACTATAAGGGTCTCCATCCTGTGCCTGCGGCTCGACCGTTGCGTGATTACATTGATTGGGTAGAAGCACAGGACAGAGGGCAGGCTATTGCTTTTTGGCGCCAGCGCGTTCAGCGCTTGCCTCGGTTGCCACCTATGCCACCACGGGCCCATGAGCACTGCTTCGTGGAGATTGACGGCATTGATGTGAGGGGGATTCTCGATACGGCGCGCAAGCAAAAGGTTGCATTCGCGACGGTGGCATTTGCCGCATGGGCACTTGTTTTGCGAGCCTCTCGGTCCAGCGACGAAGTCGTTTTTGGCATCACCGTGCATGGTCGCCCGGCAGAAATTGTGGGCGTTGAACGAATGGTCGGACCGTTCATTGCGACATTCCCCATGTACTTGCAGATGGCACACATGAGTACAACCGAGGAACTGCTGCACCAGATTGAACAGCAACAGAGTGAACAGCGGCCTTTTGAATACCTATCGGCAGCCGAGGTCCACCAGGCGGGAGGTATCGCCACTCGGCTCTATGACAGCCTGGTGGTGGTTGAACAAATTCCTCAACACAGCGCAATGGCCACTGGGGGAATATCGGTTTCTGCCGAATCCGGAAATGGCGCGCGCTCGCACCATCCTTTGTTGTTACGGTTCTCCCAGGATGGGATGGCTCGCCTCATGTACAACAAGAAGTTCTTCGATGACGAAACCGCAAGCGGACTGGTGTCTTTGTTGCGTCAAGCAGCGGTACGGCTGGCCTCGAACGACGGTCTGGTGAGCCTTGATGGCGCGATGGCGTTTTACGCCCCGATAAAGCCCAGGCCTGTGCGCATGCCTCGAAACCAGGAGGAGCACATCGTGCTTTCTCTTGCGCGTACTCTTTTCGGTGAGCACGCCACCCTTGATGACAACTTCATTGATCTGGGCGGGCATTCGTTACTCGCCGTGCAATTTATTCAACGTATCGCCCATGAGACAGGGGTGCAATTACCCATTACACAGTTCTTGCAGGATGATCGCCTCAGCTCGCTGGCGAAGGCATTGGGGGACAGCCAGGCTGGTGTTGTGGACGTCTCTCACCCCAGGATCTTATTTGTCCCGGGTAATCCTGGAACTGTCCTTTATGCGTCTCGATTGTCCGTGCACCTGGTGGATTGGCGTTTACATGGTCTTGAGGCGCCAGGGCTCGATGGCTCACAGCCGCCGCTCGCAACGGTCGAGGCATTAGCCGAGCATCACCTTGCAAGCCTTTCGGTGGACGATAACCCCACAGTGATCATCGGGCATTCCTTTGGTGGATGGGTGGCTTTCGAGATGGGGCTACGGTTACAGGCGCGTGGCCGTGAGGCCGTGGTGATTCTGCTAGACACTGTCTCCCCCTATCGATTGCTTTCCCGAGGCGATGTCTCCGACGAGGGGCTACGGGCGGAAGTCGAGCATTTGAAGATCCGTGCCGGGAGTGCTGGTATTAACGCGCACATCACGCCGGCTGTATTTGAAGTTTATGTTGCCGCCCGGCGCGCGATCTATGCACCTGCCGAGCAAGCCAGGTTCCCAATGATGTTGTTTCGGGCTTCCCAGACTCGGCCTGAGGACACCTGGGATAAAACCGCCCCCGACTATGGTTGGGGCGAACTCTGCCAGCAGCTCCATGTCGACACGATCGAGGGCGACCACCTTTCGATAATGGTCGATCCCGCAACTGAAGTATTGGCCCGCAGGATTGAGCGTTGGCTGTATCAGCTCAGCCGTTGA	MKANIQDIHGLAPSQHGMLLESTNGLTQGDMFIEQSVLLVRGKLDTPRFLSAVEQIATIHSSLRSCFAWEGETPLHVVFDKVRPVVEWEDWQSKEGADDRQTLEAWLAADRSRGLAVNRAPLWRFTVIRCAEEVHRVIWTHHHLITDGWSIAVVLNDLLDHYKGLHPVPAARPLRDYIDWVEAQDRGQAIAFWRQRVQRLPRLPPMPPRAHEHCFVEIDGIDVRGILDTARKQKVAFATVAFAAWALVLRASRSSDEVVFGITVHGRPAEIVGVERMVGPFIATFPMYLQMAHMSTTEELLHQIEQQQSEQRPFEYLSAAEVHQAGGIATRLYDSLVVVEQIPQHSAMATGGISVSAESGNGARSHHPLLLRFSQDGMARLMYNKKFFDDETASGLVSLLRQAAVRLASNDGLVSLDGAMAFYAPIKPRPVRMPRNQEEHIVLSLARTLFGEHATLDDNFIDLGGHSLLAVQFIQRIAHETGVQLPITQFLQDDRLSSLAKALGDSQAGVVDVSHPRILFVPGNPGTVLYASRLSVHLVDWRLHGLEAPGLDGSQPPLATVEALAEHHLASLSVDDNPTVIIGHSFGGWVAFEMGLRLQARGREAVVILLDTVSPYRLLSRGDVSDEGLRAEVEHLKIRAGSAGINAHITPAVFEVYVAARRAIYAPAEQARFPMMLFRASQTRPEDTWDKTAPDYGWGELCQQLHVDTIEGDHLSIMVDPATEVLARRIERWLYQLSR	MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL	71.33	gnl|BL_ORD_ID|2367|hsp_num:0	2720			2100	2298	erythromycin; tetracycline; novobiocin; aztreonam; kitasamycin; rokitamycin
BGC0001045.1|Spiruchostatin_18 # 41103 # 42008 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.588	BGC0001045.1|Spiruchostatin_18 	41103	42008	+	Loose	600	28.4906	Streptomyces venezuelae rox	38.33	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGGATACTGAACTTTCTTTAGTGAACTTCGATTTCATTGTGATCGGTGGCAGCTATGCCGGACAGTCGGCGGCAATGCAACTGGCCAGGGCTCGACGGCGGGTTCTGGTGATGGACGTCGGCGTGCGTCGCAACCGTTTTTCCCGGACGCTACACGGTTTGCCCGGGCAGGAGGGGCGCTCACCCGATGTCATTGCGCAGGAGGGGCGGGCGCAAATCATCGCTTATCCGAATGTGCAGTGGTTGGAAGAGGAGGCCACAAGTGCTGAGCGCACCAAGGCCGGATTTGTCGTCCGAGCTCAGTCGGGGCAAGGTTTTTTTGCCCCGAACGTGGTGTTGGCCACTGGTGTGGAAGACGACTTGCCGCCAGTGGACGGATTGGCCCAGCGCTGGGGGCGTAGCGTATTTCATTGCCCTTATTGCCATGGCTATGAATTGAACCAGGGCTATATCGGCGTGCTTGCGGTCGACGAAGTTGCCTATCAACTTGCATTGATGATGCTTGATTGGGGGACCGTCATTCTCCTCACCGATGGCAGGTTCGAACCCGATGAGGCTCAGCGCAAGACCTTGGCAGAATGTGGGGTGGTGATTGAGTCGCAGCGGGTGCTACGCATAGTGGATACAGCCACTGTCGAGTTGGACGATGGGCGAAAAATCGTCTTGGATGGTTTGTTCTGTGCGAGTCACACCCGTATGGCGAGCCCGATTGCCGCACAACTAGGCTGCGCCTTCGAAGAGGGGGCGATGGGGCCCTATATTTGCACCAGCGAAACCATGGAAACCTCTGTCCCTGGAGTATTTGCCTGCGGTGACATGGTTCGCATGGGGGGAACTGTCGGCCTGGCCGTGGGGTCAGGCGCCCATGCCGGACTTGCCGCGCACCGGGCGTCAGCGCAACGGTGA	MDTELSLVNFDFIVIGGSYAGQSAAMQLARARRRVLVMDVGVRRNRFSRTLHGLPGQEGRSPDVIAQEGRAQIIAYPNVQWLEEEATSAERTKAGFVVRAQSGQGFFAPNVVLATGVEDDLPPVDGLAQRWGRSVFHCPYCHGYELNQGYIGVLAVDEVAYQLALMMLDWGTVILLTDGRFEPDEAQRKTLAECGVVIESQRVLRIVDTATVELDDGRKIVLDGLFCASHTRMASPIAAQLGCAFEEGAMGPYICTSETMETSVPGVFACGDMVRMGGTVGLAVGSGAHAGLAAHRASAQR	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	63.24	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	171	rifampin; rifaximin; rifapentine
BGC0001045.1|Spiruchostatin_20 # 42968 # 43102 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.533	BGC0001045.1|Spiruchostatin_20 	42968	43102	+	Loose	250	21.1718	arr-2	52.94	3002847	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin ADP-ribosyltransferase (Arr)	ATGACACTGTTGGAGCAATGCGGCGGCCTCGACCTGAATAGCTTCATGAGCGGCAGTGGGGGCTGGACAGGTCGCAGGCCTTTCGAGCTTTTGCGCGGCGTATTTCAATCTTTATTGTTCAAGGGCAAACAATGA	MTLLEQCGGLDLNSFMSGSGGWTGRRPFELLRGVFQSLLFKGKQ	MVKDWIPISHDNYKQVQGPFYHGTKANLAIGDLLTTGFISHFEDGRILKHIYFSALMEPAVWGAELAMSLSGLEGRGYIYIVEPTGPFEDDPNLTNKKFPGNPTQSYRTCEPLRIVGVVEDWEGHPVELIRGMLDSLEDLKRRGLHVIED	29.33	gnl|BL_ORD_ID|1021|hsp_num:0	1116			363	411	rifampin; rifaximin; rifabutin; rifapentine
BGC0001045.1|Spiruchostatin_23 # 45921 # 46709 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.602	BGC0001045.1|Spiruchostatin_23 	45921	46709	+	Loose	1000	29.261	mecD	31.11	3004185	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGCACGGGCGCATCAACCTGCCTGAATCGTTTGCCGCCGAATGGAGCACGATTGCCGGCCGCGACAGTTTCGCCCATGACACGCTGAATCGACCGGGCAAGGTCGTGCGCGACAGTGAGTTCACCGACCCTGACGATCAGGTGAATGTGTTTGCACGGCGCTATGACCTCTACCACCTGATGTGTATCACCTTCGAGCTGCCTGAAAGCGGCTTGATGTTCTTTGTCTGTCTCTACCGTGGCCTTGATGCACCGGCTTTCAACGAGACGGAGGACGGTCTGTTTTCGGCCTTCTGCGACCACCTGTTGCAACTGTGGCGGTTTCAAGTGCAGGACATGATTCGCTTCGACACGGACAACGGGGCGACGGATTTCGGTGTTGCCCGTATGGACGGCAGTCTGTTGTATGTGGGTGCCAGGCTGTGCGCCGCCATTGAGCGTGAGTTGCCCGGCTGGAGCGGTTCAATGCTGCCTGAACAGGTGATTACGCAACTGCACGATGCACCGGGCGTGGTGCGTCTGGGTCGCTCGTCATTGACACTCAGCCCCCATGGCGAGCATGTGATTCTGTCACTTGAGGTGCCGTCGGGCGGGGCAGCGCTCGCGCCACGGGAGCGCACGGCCGCGATGCTGTTCGCCGCCGGCCACTCCTACAAGGAGATCGCCAAAATGCTGTCGTTGAGCCCGGCGACGGTGCGTACCTACCTGCGCAATTGTTACCTGCAACTGGGGGTCAAAAGCAAAGTGGAGCTAGGGTCCGTGCTGCGTGCGGTTGTCCGTCGCGATTAG	MHGRINLPESFAAEWSTIAGRDSFAHDTLNRPGKVVRDSEFTDPDDQVNVFARRYDLYHLMCITFELPESGLMFFVCLYRGLDAPAFNETEDGLFSAFCDHLLQLWRFQVQDMIRFDTDNGATDFGVARMDGSLLYVGARLCAAIERELPGWSGSMLPEQVITQLHDAPGVVRLGRSSLTLSPHGEHVILSLEVPSGGAALAPRERTAAMLFAAGHSYKEIAKMLSLSPATVRTYLRNCYLQLGVKSKVELGSVLRAVVRRD	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	38.64	gnl|BL_ORD_ID|2418|hsp_num:0	2828			555	690	methicillin
BGC0001045.1|Spiruchostatin_24 # 46836 # 48578 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.586	BGC0001045.1|Spiruchostatin_24 	46836	48578	+	Loose	2090	27.335	mdsB	29.63	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAACGATTTGTTCCCAGTCTGTTGGCCGCCGCTGTGGCGTTTTCCTCGGTGCAAGCGATGGCCGCTGCTGACCTTGTGCTGTTCAACGGCAAGGTATTCACCGCTGAGTCCGGACAAGAACTGGTTCAGGCGGTGGCGGTGCAAGACGGCAAGATTCTTAAAGTAGGCAGCGATGCCGAGATCACGGCCTTGGCCGATGACCATACGCAACGCATCGATCTGGCCGGCAAGGTGCTGATGCCGGGCATGATTGATAGCCATAGCCATCCGGTGGTCGCAGCCTTCGACAGCCTGGGCGCCAACTTGCTGGACGAGGTCAAACCGTTACCTGCGCTTGAGCAGTGGATCATCGAGCAGGACCAGGCGGGCAACGCGAGGGCAGGGGACGTGGTCAGCATTGCCGGGGTCAGTTCGGCCTATTGGCAACAGAGCAAGGCGCTTGGCGAGCGTTTCAATCAGGGGCGTTGGGCTGAACAACCGCTGGTGCTGAATGGGATTGACGGCCACACCGGCTGGGCCAACAACGCCATGCTCAAGCGCTTGAAAATCGATGCAGCGCTGGTAAAAAGCCTGCCGGAAGCAGAGCGTGGTTATGTGGGCCACGCAGCGGACTTCACGCCCAATGGTTATTTTGCCGAGTCGCGTTGGGATCAGGTGCGCAGCCAGATTCCTGCACCCAGTGCCGAGGTCATGTTGAAGGCTGCCCGCCTGGCGGTGCAGATCAATAATCAATATGGCGTTACCGCCTGGATGGACGCAGCGTCGAATGCCGGCCAAGGTGATTCGCTGTTTGATTTCACGGCAACTGAGCAGAGTTACGGTGTGCTGCCGCTCTACCGTGAACTGGCAGAGAAAGGGGAACTCAGCGCGCACGTTGCGGCGTTACTGATCACCAACCCGAAAAGCAAACCGGCCGACCTGGAAGTACTGGCCAAGATAATGAAGACGTTCGAGGGCGTGCCCAACCTGACCTTCCCGGGCATCAAGGTTTTTGCAGACGGCATCATGGAGTTTCCAGGGCAAACCGCTGCGGTGATCGACCCGTTCAAGAACAGCCTGAAAAACGGCCAGCTGTTAATCGACCCGGCGCACTTTGGCGAGTTGGTGGTGGCGGCGGAAAAGCGCGACTGGATCGTGCACATGCATGCTGTTGGCGACCGCGCGGTCCGTGAGTCACTCAATGGCTTTGAATACGCGCGCAAGCTTAATCCCACGCCAATGCCCCATAGCATCAGCCACCTGCAACTGGTCAACCCCAAGGAGTTTCCACGCTTCAAACAGCTGGGTGTGATTGCCTCCATGCAACTACTCTGGGCCACCGGTGAGGACTACACGGTGAAGCTGGTCAAACCCTATGTCAGTGCGTTTGCCTACCGTTACCAGTATCCCGCGCAGTCCCTGCATAAAGCCGGCGCCATGATTGCCGGAGCCAGTGATTGGCCGGTGTCCAGCCCCAACCCGTGGAACGCCATTGCTCAGGCCAGCACTCGAAAGGGACCGCTGGGGGTGTTGAATGCCAAGGAAAGTATTGACCGCCAGACCATGTTTTACGCCTACACCCTCAACGCTGCCAAAGCCCTGCGCCTGGATCAGCAGATTGGCTCACTGGCGCCCGGCAAACAGGCCGATCTGATCATCCTTGATCGCGATGTGTTCAAGGTCAGCGACGACGAACTGTTTGACACCCAGGTGCTGAAGACCTTCTTCGCCGGCAAACAGGTCTACGCGCCCGCGTCCTGA	MQRFVPSLLAAAVAFSSVQAMAAADLVLFNGKVFTAESGQELVQAVAVQDGKILKVGSDAEITALADDHTQRIDLAGKVLMPGMIDSHSHPVVAAFDSLGANLLDEVKPLPALEQWIIEQDQAGNARAGDVVSIAGVSSAYWQQSKALGERFNQGRWAEQPLVLNGIDGHTGWANNAMLKRLKIDAALVKSLPEAERGYVGHAADFTPNGYFAESRWDQVRSQIPAPSAEVMLKAARLAVQINNQYGVTAWMDAASNAGQGDSLFDFTATEQSYGVLPLYRELAEKGELSAHVAALLITNPKSKPADLEVLAKIMKTFEGVPNLTFPGIKVFADGIMEFPGQTAAVIDPFKNSLKNGQLLIDPAHFGELVVAAEKRDWIVHMHAVGDRAVRESLNGFEYARKLNPTPMPHSISHLQLVNPKEFPRFKQLGVIASMQLLWATGEDYTVKLVKPYVSAFAYRYQYPAQSLHKAGAMIAGASDWPVSSPNPWNAIAQASTRKGPLGVLNAKESIDRQTMFYAYTLNAAKALRLDQQIGSLAPGKQADLIILDRDVFKVSDDELFDTQVLKTFFAGKQVYAPAS	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	54.98	gnl|BL_ORD_ID|1269|hsp_num:0	1385			753	909	chloramphenicol
BGC0001045.1|Spiruchostatin_25 # 48691 # 49275 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.581	BGC0001045.1|Spiruchostatin_25 	48691	49275	-	Loose	2000	24.6386	oqxB	40.0	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGTCAGGGCGACTTCCCACTCGTGGTAGGAATCACGCGCATCACCACGGGTGGACCAGAACGCCGGATCCTTAACGTCGTTGTGCCCATAACGCAGTTTCAAGCCGACCTCACCTGGCAAAGTGGTGGTGTAGCCAAGGTAGGTGTAGAGGGTGGACTGGTGGTCGCCAAAGGCGTTCGGCGTATCGCGGGAGTAATAGGCGCCAAGCTGCACGCCATAGGTGTCGAGGATCGCGTAGAGCTCGCTCAGGTTGAATTGGCTTTCCTTGGGATAGCTGTACTTGATGTAGCCCAAGTCGAGGCTGATGGCATCGGTCATCTGCCAGGCATAGCCCGCGTAGTATTCAAATTCTTCGCGTGTCTTGAAGTCATCGCCAAAATCGACATTCGAAGTCCAGACACCGGCATACAGGCCGCTGCCATGCAGCAACGTGACGCCTGCCTGCACCGCCGGATCACCCAGGGTCTGCGAGATGCCACGGGTGCGATAGTCGCTGACGGCGGCCAGGCTGACCTGCAGGTTGAGGTCATCGTTGAGCGGCAGCGCTTGCGTGGTCAATGGCACCAACACAAGAAAGACTGA	MGQGDFPLVVGITRITTGGPERRILNVVVPITQFQADLTWQSGGVAKVGVEGGLVVAKGVRRIAGVIGAKLHAIGVEDRVELAQVELAFLGIAVLDVAQVEADGIGHLPGIARVVFKFFACLEVIAKIDIRSPDTGIQAAAMQQRDACLHRRITQGLRDATGAIVADGGQADLQVEVIVERQRLRGQWHQHKKD	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	18.48	gnl|BL_ORD_ID|2152|hsp_num:0	2400			2724	2829	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0001045.1|Spiruchostatin_27 # 49636 # 49983 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.615	BGC0001045.1|Spiruchostatin_27 	49636	49983	-	Loose	600	74.7146	Acinetobacter baumannii AbaQ	38.0	3004574	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGCCGCCCTGCTCGCCGGCCTAGGGCTGGCCTGCACAGGGCTGTTTATCGGGCATGCCGTGTTAGCGCTGGTCTCCCTGACACTGGCCGCCATGGGTATCCTGGCAGCGTTTCCAGTGTTCTGGTCGATTCCAGGGGCCTTCCTGGCCGGTACCGCTGCGGCCGGCGGCATCGCCTTGATTAACTGCATCGGCAACCTTGCCGGGTTCGTTGCGCCCTACATGATCGGCTGGCTGAAAACTCTGACCGGTAGCTTGTCCGCGGGCCTGTATCTGGTCGCCTGTTTTGAAGTGCTGGCCGGGGTGTTGCTGCTGTTGTTATTCAACGGGGTGAAAGTCAGTAAGTAG	MAALLAGLGLACTGLFIGHAVLALVSLTLAAMGILAAFPVFWSIPGAFLAGTAAAGGIALINCIGNLAGFVAPYMIGWLKTLTGSLSAGLYLVACFEVLAGVLLLLLFNGVKVSK	MDFEKDVIRTVTFKLIPALVILYLVAYIDRAAVGFAHLHMGADVGIGDAAYGLGAGLFFIGYFLFEVPSNLLLDKFGARKWFTRILLTWGLITMAMALIQGPKSFYLLRFLLGVAEAGFFPGVLYLITQWYPVRHRGKIMGMFVLSQPIAMMIAGPLAGLLLGMDGIANLHGWQWLFVAVGLPAVLLALPTFLWLPDNIDKVKWLSIEQKQWLKNELVKDEAEYDQTRHANPLHALKDKRVLLLALYYLPVTLSIYGLNLWLPTIIKQFGGGSDIQIGFLSSIPYIFGIIGLLIIPRSTDRLNDRYGHLSFLYALGACAMFLSGWLNSPVMQLAALAVVAFCLFSSTAVFWTLPGRFLTGASAAAGIALINSVGNLGGYVGPFGIGLLKEYTGNMAAGLYFLSIVMLFGLILTYIVYAKLERQKTQTVNIQKPL	26.50	gnl|BL_ORD_ID|2717|hsp_num:0	3278			972	1272	
BGC0001045.1|Spiruchostatin_30 # 52498 # 53157 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.606	BGC0001045.1|Spiruchostatin_30 	52498	53157	+	Loose	550	29.261	Sed-1	29.51	3003561	protein homolog model	n/a	n/a	cephalosporin; penam; penem	antibiotic inactivation	Sed beta-lactamase	GTGACGCAGGCTGCGGTTGAGGATGGGGTCGAACAATTCCATTTCAAAGGCTTCGCCGTAGCCCAGTTCGCCGATCACCGATTGCGTGCCGCAAAACATCGCGGTGTCGGCGGGCAACGAGGCTTCGTGGTTCAGTTTTGCCAACAGGGTTTCCGGAGCCAGCAGGTTGGTCACCGGGCCTTGTTGGTAGAGCGCACGCACACCGTCACGCACGCGCCAGGTGCGCATGACCAGTTGGTCCCAATGCCCCTGGACTTCGCTGTAGCGCCACACTTGCTGGGCGATAGGCTTGTCGCACATCTGCTTGGACACGGTGACGTCATAGCTTTCAACCTTGCGGTCGGTGTGGTCCGAACCCAGGCCGATCAAGAGACCTTGCTCGCTGGGCAGGAGCACGAACTCAGTTTCCCCGGAGGAGTCCTTGCCAGGCACCTGGATGGTCTCAGCATTGTTCAGCAGGCTGGCCGATACCCGGTAGAAACACGGAACCTGAGTTGGGCGGCGCACCCCCAGTGCTTCGAGTTCGGCGATGTGATGCTCCACCGCTTCGCTGTTACGTCCCGCCCAGCCCGCGATAATCAGGTGCTTGATGCTGGCGCGGTGTTCGCCCTGGCCGACGACGTGGAAGGTCAATTGAGTCATGAAAAGCTCTCGTGGTGA	MTQAAVEDGVEQFHFKGFAVAQFADHRLRAAKHRGVGGQRGFVVQFCQQGFRSQQVGHRALLVERTHTVTHAPGAHDQLVPMPLDFAVAPHLLGDRLVAHLLGHGDVIAFNLAVGVVRTQADQETLLAGQEHELSFPGGVLARHLDGLSIVQQAGRYPVETRNLSWAAHPQCFEFGDVMLHRFAVTSRPARDNQVLDAGAVFALADDVEGQLSHEKLSW	MLKERFRQTVFIAAAVMPFIFSSTSLHAQATSDVQQVQKKLAALEKQSGGRLGVALINTADNSQVLYRADERFAMCSTSKVMTAAAVLKQSETHDGILQQKMTIKKADLTNWNPVTEKYVGNTMTLAELSAATLQYSDNTAMNKLLAHLGGPGNVTAFARSIGDTTFRLDRKEPELNTAIPGDERDTTSPLAMAKSLRKLTLGDALAGPQRAQLVDWLKGNTTGGQSIRAGLPAHWVVGDKTGAGDYGTTNDIAVIWPEDRAPLVLVTYFTQPQQDAKWRKDVLAAAAKIVTEGK	74.24	gnl|BL_ORD_ID|1202|hsp_num:0	1294			426	606	cefuroxime; amoxicillin; piperacillin; cefalotin; ticarcillin
BGC0001045.1|Spiruchostatin_32 # 53903 # 54178 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.565	BGC0001045.1|Spiruchostatin_32 	53903	54178	+	Loose	500	24.2534	OXA-621	31.37	3005842	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCCTGTGCCAGTTTTTCAGGAACTGGCCAAAGGCGCGGTTTATAAGGGATTGGCGGAATCAGCGGTACGCTGGAGGGCAGGGCGGGCGATGTTGCTTGTTACTTTTGTGCCCGGCTTTGAGCCGGTGTGCTCGATGTTTGTGCGGGCGAGGTATCAACTTAAAGGCGCTCTGGGAGGACCTGGCGCATCATGCCGTTGCGCCTTTCAAGAAGATCGAGATGAGAAACTCGGGCCCTTGGCGTTTGCCCATCGACTCATCGTCGATCAGGTCTGA	MPVPVFQELAKGAVYKGLAESAVRWRAGRAMLLVTFVPGFEPVCSMFVRARYQLKGALGGPGASCRCAFQEDRDEKLGPLAFAHRLIVDQV	MRDFIVFIWFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFQRAKQAFSPASTFKIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPVFKELARKIGLKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKNQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLNKYLANFSNNNRIKSFY	35.41	gnl|BL_ORD_ID|3877|hsp_num:0	4947			324	471	cloxacillin; oxacillin; cefalotin
BGC0001045.1|Spiruchostatin_33 # 54092 # 54334 # -1 # ID=1_33;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.593	BGC0001045.1|Spiruchostatin_33 	54092	54334	-	Loose	310	35.4242	Type B NfxB	36.99	3004060	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATCGAGACGTTGCTGTCCGACCTGGCGGCGCGGGTCGAAACAATTAATGCCCGGCTCGTTGCATTCTTTGAGCGGGGTCAGCAGGCCGGGCTGTTTCGCCAGGACCTTCCGGCAGCCTGGATGACGGGGGCATTTCAGGGGCTGTGCGAAACCACGTCAGACCTGATCGACGATGAGTCGATGGGCAAACGCCAAGGGCCCGAGTTTCTCATCTCGATCTTCTTGAAAGGCGCAACGGCATGA	IETLLSDLAARVETINARLVAFFERGQQAGLFRQDLPAAWMTGAFQGLCETTSDLIDDESMGKRQGPEFLISIFLKGATA	MTLISHDERLIKALAVAIVDRPRATLKELAEAAGVSKATLHRFCGTRDNLVQMLEDHGETVLNQIIQACDLEHAEPLEALQRLIKEHLTHRELLVFLVFQYRPDFLDPHGEGARWQSYLEALDAFFLRGQQKGVFRIDITAAVFTELFITLVYGMVDAERRGRAASSNSAHTLEQMFLHGASNPARS	42.78	gnl|BL_ORD_ID|2342|hsp_num:0	2693			336	546	erythromycin; gentamicin C; tetracycline; novobiocin; trimethoprim; chloramphenicol; ofloxacin; gentamicin
